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Abstract 
 
The aromatic amino acids play a vital role in both biology and pharmacology areas. On 
one hand, they are the essential building blocks of protein, which can carry out many 
crucial bodily functions. On the other hand, these substances are recognized as chiral 
drugs containing a racemate and two enantiomers. In addition, the special aromatic ring 
adds a complex structure to this kind of amino acids. As a result, the investigation of the 
aromatic amino acids gains great significance and can provide people some practical 
ideas in the researching works about protein. 
This thesis presents a comprehensive study on the characterization and crystallization of 
aromatic amino acids. In the first part, diverse recognition methods were applied to 
characterize the L-tryptophan (L-Try), such as X-ray single crystal and powder 
diffraction analyses, differential scanning calorimetry, as well as measurement of solid-
liquid equilibrium in water/isopropanol solution. The absence of eutectic point was 
demonstrated by the binary melting point diagram and the ternary phase diagram, which 
indicated the existence of a pseudoracemate (i.e., solid solution). The racemate, 
enantiomers, and the mixtures of them gave the identical powder X-ray diffraction 
patterns, and the X-ray single crystal analysis showed that the racemate and enantiomers 
of tryptophan gained very similar solid-state packing geometries, which confirmed the 
conclusion above. As a result, all the thermodynamic and crystallographic analyses have 
supported the conclusion that the tryptophan crystallized as a pseudoracemate. 
The second part of this thesis mainly focused on the study of the effect of tailor-made 
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impurity on the crystallization process. The influences of L-tyrosine (L-Tyr) on the 
solubility, crystallization kinetics, and polymorphism of L-phenylalanine (L-Phe) were 
respectively investigated. The results indicated that the presence of L-Tyr could increase 
the solubility and the crystal nucleation rate of L-Phe in water, however, the growth of L-
Phe on a certain direction would be suppressed and thus the formation of polymorphs 
became unavoidable. Specifically, the addition of L-Tyr could make the anhydrate form 
of L-Phe more stable at 24 °C.  
  
iii 
Co-Authorship Statement 
 
Chapter 3: A version of chapter 3 was published as:  
 Li Y., Y.M. Zhao, Y. Zhang. Solid tryptophan as a pseudoracemate: 
physicochemical and crystallographic characterization. Chirality 2014; doi: 
10.1002/chir.22399. 
The experiments were designed by Dr. Y. Zhang. The data were collected by the author. 
The manuscript was written by the author and revised by Dr. Y. Zhang and Dr. Y.M. 
Zhao. 
 
 
 
 
 
 
 
 
 
  
iv 
Acknowledgement 
 
First and foremost, I am heartily grateful to my supervisor, Dr. Yan Zhang, a respectable, 
responsible, and resourceful scholar. Her encouragement, support, and guidance for my 
research make me confident and motivated to continue my research in chemical and 
process engineering. I also appreciate the financial support from Natural Sciences and 
Engineering Council of Canada through Discovery Grant and Memorial University of 
Newfoundland. I could not finish this research without their support. 
I shall extend my  gratitude to Dr. Yuming Zhao, who has provided me with valuable 
guidance in preparing my first paper. 
I would also like to thank Ms. Julie Collins at C-CART, Memorial University of 
Newfoundland for helpful discussions on the single crystal structure of DL-Try. My 
gratitude also goes to Mr. Xiong, and Mdm. Mao, for all their kindness and help.  
Last but not least, I'd like to thank all my friends for their encouragement and support. 
 
  
v 
Table of contents 
Abstract i 
Acknowledgement iv 
Table of contents v 
List of Figures viii 
List of Tables xii 
List of Abbreviations and Symbols xiii 
Chapter 1 Introduction   1 
1.1 Problem Statement 2 
1.2 Objective and Scope of Study 4 
1.3 Thesis Outline 5 
Chapter 2 Literature Review 7 
2.1 Amino Acids 7 
2.2 Crystallization of Amino Acids 10 
2.2.1 Crystallization from solution 10 
2.2.2 Factors affecting the crystallization of amino acids 12 
2.2.2.1 Chirality of amino acids 12 
2.2.2.2 Polymorphism of amino acids 16 
2.3 Characterization of Chiral Modifications of Amino Acids 18 
2.4 Effect of Foreign Molecules on the Crystallization of Amino Acids 23 
2.4.1 Effect on the solubility 23 
2.4.2 Effect on the nucleation 25 
2.4.3 Effect on the crystal growth 27 
2.4.4 Effect on the polymorphism 29 
Chapter 3 Solid Tryptophan as a Pseudoracemate: Physicochemical and 
Crystallographic Characterization 33 
vi 
3.1 Introduction 33 
3.2 Materials and Methods 38 
3.2.1 Materials 38 
3.2.2 Differential scanning calorimetry 38 
3.2.3 Solubility measurement 39 
3.2.4 Powder X-ray diffraction 40 
3.2.5 Single-crystal growth and structure determination 40 
3.3 Results and Discussion 41 
3.3.1 Absence of eutectic melting 41 
3.3.2 Ternary solid-liquid equilibria 44 
3.3.3 Powder X-ray diffraction 47 
3.3.4 Single crystal structures of DL- and L-Try 48 
3.4 Conclusions 54 
Chapter 4 Effects of Structure Similar Additive on the Crystallization of L-
Phenylalanine from Aqueous Solution 56 
4.1 Introduction 56 
4.2 Material and Methods 59 
4.2.1 Material 59 
4.2.2 Preparation of L-Phe anhydrate and monohydrate 59 
4.2.3 Solubility and metastable limit measurement 60 
4.2.4 Seeded batch crystallization of L-Phe in the absence or presence of L-Tyr 61 
4.2.5 Characterization methods 62 
4.3 Results and Discussion 63 
4.3.1 Characterization of L-Phe anhydrate and monohydrate 63 
4.3.2 Effect of L-Tyr on the solubility of L-Phe 65 
4.3.3 Effect of L-Tyr on primary nucleation of L-Phe 67 
4.3.4 Effect of L-Tyr on the growth and morphology of L-Phe 69 
4.4 Conclusion 75 
Chapter 5 Conclusions and Recommendations 77 
vii 
5.1 Conclusions 77 
5.1.1 Characterization of L-Try 77 
5.1.2 The effect of L-Tyr on the crystallization of L-Phe 78 
5.2 Recommendations 78 
References 80 
 
  
viii 
List of Figures 
 
Figure 2.1          Structure of amino acids                                                                            7 
 
Figure 2.2          The formation of proteins                                                                          7 
 
Figure 2.3          Structural diagrams of phenylalanine (a); tryptophan (b); and tyrosine  
                          (c)                                                                                                               9 
 
Figure 2.4          Classification of nucleation                                                                     11 
 
Figure 2.5          Classification of the chiral system                                                           13 
 
Figure 2.6          Binary phase diagrams of (a) conglomerate; (b) racemic compound; (c)  
                          solid solution: 1, ideal; 2, with a maximum; or 3, with a minimum        14 
 
Figure 2.7          PXRD spectra of the (a) α-glycine and (b) γ-glycine crystals (Srinivasan  
                          et al., 2011)                                                                                               17 
 
Figure 2.8          DSC curves of the (a) α-glycine and (b) γ-glycine crystals (Srinivasan et  
                          al., 2011)                                                                                                  18 
 
Figure 2.9          Photographs of the glycine polymorphs (Srinivasan et al., 2011)           18 
 
Figure 2.10        Binary melting point phase diagram of the mandelic acid (Lorenz et al.,  
                          2002)                                                                                                        20 
 
Figure 2.11        Ternary (solubility) phase diagram of mandelic acid  
                          (Lorenz et al., 2002)                                                                                 20 
 
Figure 2.12        Powder XRD patterns of (R)-3-ClMA and (RS)-3-ClMA (Zhang et al.,  
                          2009)                                                                                                        22 
 
Figure 2.13        Mole fraction solubility of L-phenylalanine anhydrate from 293.00 to  
                          308.00 K and monohydrate from 312.00 to 328.00 K in pure water and  
ix 
                          aqueous solution in the presence of four salts: ◆,pure water; ▲,  
                          potassium chloride; ■, sodium sulfate; ●,ammonium sulfate; −, sodium    
                          chloride (Wang et al., 2014)                                                                     24 
 
Figure 2.14        Electron micrographs of L-Glu crystallized with L-Phe: (a) no additive,  
                          (b,c) 1×10
-2 
M; (d) 2×10
-2
 M. (L-Glu= 0.3 M) (Cashell et al., 2005)      31 
 
Figure 2.15        PMG crystallized from pure solution (a) and from impurity-doped  
                          solutions (1.0 wt% on PMG): (b) IMPA, (c) AMPA, and (d) PIDA  
                          (Poornachary et al., 2008)                                                                        31 
 
Figure 2.16        Four different positions for the imposter L-Alanine to replace glycine  
                          molecules and form dimers within the unit cell (Kuvadia et al., 2013)   32 
 
Figure 3.1          Melting point phase diagrams for pseudoracemates: Type I-ideal  
                        solution; Type II-solution with maximum melting temperature; Type III-  
                        solution with minimum melting temperature                                             35 
 
Figure 3.2          Molecular structures of D- and L-tryptophan                                          37 
 
Figure 3.3          DSC curves of tryptophan with various mass fraction of L-Try             42 
 
Figure 3.4          DSC curves of enantiomeric mixtures with mass fraction of L-Try  
                           identical or close to the calculated eutectic composition                        43 
 
Figure 3.5          Binary melting point diagram of tryptophan system                               44 
 
Figure 3.6          Ternary phase diagram of tryptophan system in H2O/IPA                       46 
 
Figure 3.7          Powder XRD patterns of tryptophan with various mass fraction  
                          of L-Try                                                                                                    48 
 
Figure 3.8          (a) ORTEP plot of D-Try at 50% probability ellipsoids with atomic  
                           numbering. (b)  Four molecules in the unit cell of DL-Try                    50 
 
Figure 3.9          Hydrogen bonding packing of (a) DL-Try and (b) L-Try (The numbers  
                           identify three types of hydrogen bonds)                                                 52 
x 
 
Figure 3.10        Comparison of the N – H ∙∙∙ π hydrogen bond of (a) DL-Try and (b)  
                           L-Try                                                                                                       54 
 
Figure 4.1          Molecular structure of L-phenylalanine                                                  57 
 
Figure 4.2          Molecular structure of L-tyrosine                                                            57 
 
Figure 4.3          Micrograms of seed crystals in size range between 212 and 180μm      60 
 
Figure 4.4          Powder X-ray diffraction patterns for two products of L-Phe                64 
 
Figure 4.5          The DSC curves of two products of L-Phe                                             65 
 
Figure 4.6          The DSC curves of two products of L-Phe from 50 to 150℃                 65 
 
Figure 4.7          Solubility of L-Phe from 293.15K to 338.15K in pure water  
                          (experimental result and some data reported in literature)                      66 
 
Figure 4.8          The effects of different amounts of L-Tyr on solubility and MSZW of  
                           L-Phe                                                                                                       67 
 
Figure 4.9          Crystal products obtained in the absence (a) and presence (b)  
                          of L-Tyr                                                                                                    70 
 
Figure 4.10        Scanning electron micrographs of two crystallization products at 24℃:  
                          (a), (b) L-Phe with 4% L-Tyr; (c), (d) pure L-Phe                                   71 
 
Figure 4.11        Powder X-ray diffraction patterns of product from pure L-Phe at 24℃  
                          (Lu et al., 2012)                                                                                        72 
 
Figure 4.12        Powder X-ray diffraction patterns of product from L-Phe with 4% L-Tyr  
                          at 24℃                                                                                                      72 
 
Figure 4.13        Differential scanning calorimetry curves of two crystallization products  
                          at 24℃                                                                                                      74 
 
xi 
Figure 4.14        DSC curves of two crystallization products from 50 to 150℃                74 
 
Figure 4.15        DSC curves of contrast samples of anhydrate L-Phe to quatify the  
                          impurity amount in the final product                                                       75 
 
  
xii 
List of Tables 
 
Table 2.1          Some reported chiral modifications of amino acids                                  14 
 
Table 3.1          Solid-liquid equilibria of the enantiomer mixtures of tryptophan in  
                         H2O/IPA at T = 20°C                                                                                 46 
 
Table 3.2          Crystal structure data of DL- and L-Try                                                   49 
 
Table 3.3          Geometric characteristics of hydrogen bonds in the crystal structures of  
                         DL- and L-Try (distance in Å, angle in °)                                                 53 
 
Table 4.1          Effect of L-Tyr on the MTZW                                                                  68 
 
Table 4.2          Effect of L-Tyr on the induction time                                                       69 
 
  
xiii 
List of Abbreviations and Symbols 
 
Try                Tryptophan 
 
Phe                Phenylalanine 
 
Tyr                 Tyrosine 
 
ADHD          attention deficit-hyperactivity disorder 
 
ADD             attention deficit disorder 
 
SMB             simulated moving bed 
 
XRD             X-ray diffraction 
 
DSC              Differential scanning calorimetry 
 
DTA              Differential thermal analysis 
 
SEM              Scanning electron microscope 
 
IR                  Infra- red spectroscopy 
 
NMR             Solid state nuclear magnetic resonance spectroscopy 
 
BMP              binary melting point phase diagram 
 
TPD               ternary phase diagram 
 
HPLC            High-performance liquid chromatography 
 
UV                Ultraviolet 
 
ATR-FTIR     Attenuated total reflection−Fourier transform infrared 
 
xiv 
FBRM           Focused beam reflectance monitoring 
 
IPA                Isopropyl alcohol 
 
CCDC           Cambridge Crystallographic Data Centre 
 
∆ℎ𝑓               Enthalpies of fusion 
 
𝑇𝑓                 Melting temperature 
 
xeu                 Eutectic composition 
 
SLE              Solid-liquid equilibria 
 
xL                  Mass fraction of L-Try in the enantiomer mixtures of tryptophan 
 
χ                    Torsion angles 
 
J                    Crystal nucleation rate 
 
S                   Degree of supersaturation 
 
γ                    Interfacial tension 
 
ν                    Molecular volume 
 
G                   Crystal growth rate 
 
Δc                  Supersaturation, concentration driving force 
 
1 
 
Chapter 1 Introduction 
 
Amino acids are widely used as nutritional additives for human food, animal feed 
supplements and chemical intermediates in pharmaceutical, therapeutic and cosmetics 
industry. Because amino acids play central roles both as building blocks of proteins and 
as intermediates in metabolism, they are of great importance to human body. With the 
increase in world population and standard of living, the demand of amino acids is 
expected to grow steadily. According to a recent statistical report, the U.S. market for 
amino acids representing 20% of the global market, is nearly $1.6 billion in 2011 and is 
likely to exceed $1.8 billion by 2016. The global amino acid market is expected to be 
worth over $9.4 billion by 2018 at an estimated annual growth rate of 2.4% 
(http://www.transparencymarketresearch.com/commercial-amino-acids.html). Therefore, 
it is important to develop cost-effective and large-scale production technology to make 
amino acids more economical and thereby increasing the user base and usage rate. 
Crystallization is one of the most frequently utilized separation and purification 
operations in industry for producing solid products with desired particle size distribution. 
To produce high purity amino acids in large scale, crystallization process is economically 
attractive because of its high efficiency and productivity. The primary objective of this 
study is to apply crystallization method to prepare two enantiometic pure aromatic amino 
acids in the desired crystal form.   
 
  
2 
1.1 Problem Statement 
Crystallization is essentially a supramolecular process by which an ensemble of randomly 
organized molecules (solute) in a solution bind together to form an ordered three-
dimensional molecular array (Davey and Garside, 2000). Crystallization process defines 
final products with both chemical purity and physical properties such as particle habit and 
size, crystalline forms (referred to as polymorph) and degree of crystal imperfection 
(Poornachary, 2007). Applying crystallization to obtain amino acids with high chemical 
purity and uniform crystals in the desired form is not easy. The main technical challenges 
are threefold. First, nearly all amino acids are chiral molecules. Although the α-amino 
acids are ubiquitous in natural materials, industrially it is more convenient to produce 
racemates, a racemic mixture having equal quantities of the pair of enantiomers with 
chemical syntheses. Due to the fact that enantiomers of a racemic mixture may have 
different pharmacological effects in biological systems, regulators increasingly demand 
that chiral molecules are administrated in optically pure form. Nevertheless, the optically 
pure molecules are not always attainable by crystallization due to the formation of solid 
solution (Jacques et al., 1981). Second, the complex interaction of amino acid molecules 
with solvent molecules leads to the aggregate of different crystalline forms during the 
crystallization process. Polymorphic solids have different unit cells and thus display 
different physical properties, stability and bioavailability (Black and Davey, 1988). The 
prevalence of polymorphism in solid amino acids (Fleck and Petrosyan, 2014) makes the 
control of the crystallization process even more difficult. Moreover, the interference 
between the impurities with the normal crystal growth influences the key crystal 
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attributes particularly when the impurities have a molecular structure similar to that of the 
primary solute.  
To obtain the optically pure amino acids by crystallization, two main approaches have 
been developed, i.e., direct enantioselective crystallization (Jacques et al., 1981) and 
resolution by diastereomeric salt formation (Kozma, 2002). In terms of their phase 
diagrams, solid amino acids can occur as conglomerates, racemic compounds or solid 
solutions (Jacques et al., 1981). Among the 20 proteinogenic amino acids, arginine and 
threonine form conglomerate, serine and tryptophan belong to solid solution, others 
crystallize as racemic compound (Guijarro and Yus, 2009; Li et al, 2014). Direct 
enantioselective crystallization has been widely used to prepare enantiopure amino acids 
for conglomerate or compound forming systems, such as asparagine (Petruševaka-
Seebach et al., 2010), methionine (Polenske and Lorenz, 2009) and threonine (Profir and 
Matsuoka, 2000; Eicke et al., 2013). For solid solutions (serine and tryptophan) or 
racemic compounds with high eutectic composition (histidine and leucine), direct 
enantiselective crystallization is not applicable. Resolution via diastereomeric salt 
formation is the only choice by crystallization resolution. However, to find the proper 
resolving agent for this process is more or less by trial and error (Kozma, 2002). There is 
no rational guidance on the selection of resolving agent. 
The precise control of polymorphs and solvated crystals is important to obtain highly 
functional amino acid crystals. Based on the research works published on the 
crystallization on amino acids (Black and Davey, 1988; Boeyens et al., 2008), it was 
found that the crystallization of amino acids is highly sensitive to any changes in 
conditions (temperature, supersaturation, cooling rate), impurities, solvent, seeding, aging 
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of the solution, etc. Often, exotic conditions (droplets of particular sizes, tailor-made 
additives, external electric fields, etc.) are necessary to obtain a specific polymorph 
(Boeyens et al., 2008, Kitamura, 2003). More systematic work need to be carried out to 
thoroughly understand the aggregation behavior of polymorphous crystals for amino 
acids. 
It has been long recognized that the presence of small amounts of impurities can have 
substantial effects on crystal nucleation, growth and morphology (Klug, 1993; Weissbuch 
et al., 1995). Numerous experimental and computational efforts have been devoted to the 
investigation of the effect of impurities, particularly the tailor-made additives on the 
crystallization of amino acids (Anuar et al., 2012; Mohan et al., 2001; Mojibola et al., 
2014; Yang et al., 2013). Impurities in most cases inhibit crystal growth, but they can also 
promote crystal growth in some cases. The retarding effect is attributed to the competitive 
adsorption and surface migration between solute and impurity molecules. However, the 
promotion effects of impurities are not comprehensively understood so far (Yang et al., 
2013). The impact of foreign molecules (impurities or additives) on crystal growth results 
in the morphological changes of crystals. Thereby, control of crystal morphology can be 
achieved by the use of tailor-made additives. 
 
1.2 Objective and Scope of Study  
To address the main technical challenges in the crystallization of amino acids, the current 
study focuses on the crystallization study of two aromatic amino acids, tryptophan and L-
phenylalanine. The main objective of this study is to find the most suitable conditions 
which can help to obtain the enantiomeric pure products in the desired stable crystal 
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forms. The thesis work will comprise the following milestones: 
 Characterize the racemic modification of tryptophan by various approaches so that 
proper crystallization process can be applied to obtain enantiopure tryptophan 
 Determine the effect of impurity (L-tryosine) on the nucleation, growth and 
morphological change of L- L-phenylalanine by performing batch cooling 
crystallization experiments in the presence and absence of impurity.  
Research worked carried out in this study is never reported before. In contrast to other 
standard amino acids, tryptophan does not crystallize readily. Therefore, research works 
on the solid nature, the growth of crystals and, consequently, the determination of the 
crystal structure of both the pure enantiomer and the racemate are seldom found. As for 
L-phenylalanine, although many studies on the solubility and polymorph transformation 
have been conducted, this is the first attempt to study the effect of tailor-made additive on 
the nucleation, growth and polymorphic transformation of L- phenylalanine at room 
temperature. This study aims to expand the understanding of the characterization methods 
and crystallization process of chiral aromatic amino acids and provide useful information 
for the large-scale preparation/crystallization of these two amino acids. 
 
1.3 Thesis Outline 
Following this brief introduction, a review on chirality and polymorphism of amino acids, 
characterization of solid nature of amino acids and impurities effect on crystallization of 
amino acids has been carried out in chapter 2. In chapter 3, experimental characterization 
of solid nature of tryptophan system was carried out. X-ray single crystal, powder x-ray 
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diffractions (PXRD), differential scanning calorimetry (DSC), and solid-liquid equilibria 
(SLE) in a water/isopropanol solution. The absence of the eutectic points in the melting 
point diagram and ternary phase diagram, the structural analysis of single crystal, and the 
PXRD spectrogram all indicate that the formation of a pseudoracemate of solid 
tryptophan.  
In chapter 4, the effect of L- Tyr on the crystallization of L-Phe in the aqueous solution 
was investigated. The impurity influence on the solubility was firstly measured and then 
the kinetic effects on the crystal nucleation and the growth process were respectively 
analyzed. In addition, the occurrence of polymorphs on the presence of L-Tyr was 
investigated by applying scanning electron microscope (SEM), DSC, and PXRD 
methods.  
Major conclusions of this study were summarized and the recommendations for future 
work were proposed in Chapter 5. 
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Chapter 2 Literature Review 
 
2.1 Amino Acids 
Amino acid, a kind of important organic compound, is composed of amine (-NH2), 
carboxylic acid (-COOH), and a specific side chain which changes with different amino 
acids (Figure 2.1). Amino acids are the building blocks of proteins. They join together to 
make up the chains called peptides and then form the polypeptides or proteins (Figure 
2.2). Proteins play an important role in the activities and function of people, plants, and 
all other forms of life on earth. As a consequence, the study of amino acids possesses 
great significance and potential values.  
 
 
Figure 2.1 Structure of amino acids  
 
 
Figure 2.2 The formation of proteins 
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The standard amino acids are generally classified based on their side chains, for instance, 
the amino acids with electrically charged side chains: arginine, histidine, lysine, aspartic 
acid, and glutamic acid; the amino acids with polar uncharged side chains: serine, 
threonine, asparagine, and glutamine; the amino acids with hydrophobic side chains: 
alanine, valine, isoleucine, leucine, methionine, phenylalanine, tyrosine, and tryptophan; 
the special cases: cysteine, selenocysteine, clycine, and proline (Wu et al., 2013).  
All the amino acids except glycine are chiral molecules. Specifically, almost all the 
amino acids exist in two optical enantiomers: D-form and L-form, with D-form being a 
non-superposable mirror image of L-form. It is important to note that most amino acids 
found in proteins contain only L-configuration. Ronald Breslow, a professor in Columbia 
University, concluded that proteins must contain only one chiral form of amino acids, left 
or right. A random mixture of two orientations will cause the out of action (Breslow et al., 
2008). In this thesis, phenylalanine, tyrosine, and tryptophan, three of the amino acids 
with hydrophobic side chains were mainly investigated. Each of these three chemicals 
has an aromatic ring, which induces the very similar structures for these three amino 
acids. For the three aromatic amino acids, the effective forms are all left-handed.  L-
tryptophan (L-Try) is one of the essential amino acids and frequently used in the fields of 
medicine, food and feed additives (Chen et al., 2012; Li et al., 2005; Altria et al., 1996).
 
It 
can be transported into the brain and induces an increasing in the amount of serotonin in 
the brain, which performs as a contributor to feelings of well-being and happiness (Bretti 
et al., 2012). In addition, L-Try is effective in many medicinal processes. For example, it 
is useful in treating the insomnia, sleep apnea, depression, anxiety, and facial pain. L-
Phenylalanine (L-Phe) plays an important role in the food, pharmaceutical and chemical 
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industries. Specifically, an important application of L-Phe is to produce the aspartame (a 
kind of common sweeteners) in industry. Furthermore, it is used for depression, attention 
deficit-hyperactivity disorder (ADHD), Parkinson's disease, chronic pain, osteoarthritis, 
rheumatoid arthritis, and alcohol withdrawal symptoms (Zhou et al., 2012; Chibata et al., 
1986). L-tyrosine (L-Tyr) cannot be synthesized by humans’ body; it needs to be 
converted from the L-Phe. People can take tyrosine for depression, stress, attention 
deficit disorder (ADD), ADHD, the inability to stay awake, and improving alertness 
following sleep deprivation (Chibata et al., 1986).
 
 
 
                                
     (a)                                                                   (b) 
       
                                                                             (c)                      
Figure 2.3 Structural diagrams of phenylalanine (a); tryptophan (b); and tyrosine (c) 
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2.2 Crystallization of Amino Acids 
2.2.1 Crystallization from solution 
Crystallization is a low cost and simple operation, which is widely used in industry 
production. Products obtained from crystallization process are more stable, regular and 
convenient to transport. As a result, this technique is an ideal choice for separation and 
purification of most industrial chemical compounds. 
Basically crystallization is a phase transition, in which a crystalline product can be 
obtained from a solution. The solution is usually a mixture and normally thought of 
liquid; however, such solution may include solid and even gas (Myerson et al., 2002). 
Specifically, the crystallization can also be conducted from a molten liquid or 
supercritical liquid. An exact investigation of the solubility data is the prerequisite of the 
crystallization, because the supersaturation is the fundamental driving force for this 
process. It is well known that the four major ways to achieve supersaturation and then 
induce the crystallization are: changing the temperature; evaporating the solvent; adding 
some chemicals; and changing the composition of the solvent.  
Crystallization from solution can be elaborated as a two-step process: the "birth" of new 
crystals, and the growth of these crystals. These two steps are defined as crystal 
nucleation and growth, respectively (Myerson et al., 2002). The nucleation, performs as 
the beginning of the phase transition process during which a large number of crystalline 
nuclei appear, includes the primary nucleation and the secondary nucleation (Figure 2.4). 
The primary nucleation usually occurs spontaneously, in turn, the secondary nucleation 
results from the presence of crystals in the supersaturated solution. As soon as the nuclei 
are stable in the supersaturated system, they start to grow to the visible and larger size, 
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which is called the crystal growth. Two widely reported methods can be used to measure 
the nucleation kinetics: the first method is based on the variations for the induction time, 
and the second one is based on the variations for the metastable zone width (MSZW) 
(Kulkarni et al., 2013). The induction time is the time interval between the occurrence of 
the supersaturation and the apparent detection of the formation of the crystals. The 
metastable zone width is defined as the temperature difference between the 
supersaturation temperature and the temperature at which crystals are detected under a 
constant cooling rate (Kadam et al., 2011). The common techniques for measuring the 
crystal growth rates contain monitoring the change of crystal population (by methods that 
measure particle size and number, like FTIR) and observing the individual growth rates 
by the microscopic method (Kuldipkumar et al., 2007).
 
 
 
Figure 2.4 Classification of nucleation (Mullin, 2001) 
 
Polymorphism is a phenomenon that a solid material exists in more than one forms or 
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crystal structures. It commonly occurs in crystalline products. Polymorphs exhibit 
different lattice types and thus have different crystal shapes, which can be easily 
identified by microscopic observation. Different polymorphs of a given substance will 
possess different physical properties, such as melting point, solubility, density, hardness, 
and thermal properties, etc (Mullin, 2001).  
The quality of crystallization process depends on the shape of crystals and crystal size 
distribution. Large crystals with uniform size (a narrow size range) are easier to 
centrifuge, filter, wash, pack, transport, and store. Additionally, larger crystals have a 
smaller surface area to volume ratio, which results in a higher purity. The crystalline 
shape is also important to crystallization. Take some pharmaceuticals for example; 
different crystal faces perform different dissolution rates, which lead to different 
bioavailability (Myerson et al., 2002). As a result, the measurement and control of 
crystalline shape and crystal size distribution are essential and significant for 
applications. Some external factors and operating parameters could affect the quality of 
the final crystal products, such as the cooling rate, the stirring rate, the initial 
concentration, solvent types, the temperature, and the existence of impurities (Kulkarni et 
al., 2013). Various experiments should be conducted to explicitly understand the 
influence of each factor so that a better procedure can be determined to produce the 
desired chemicals  
 
2.2.2 Factors affecting the crystallization of amino acids 
2.2.2.1 Chirality of amino acids 
All the amino acids except glycine belong to chiral systems. They possess two optically 
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active, asymmetric forms, which are called enantiomers. One enantiomer is recognized as 
D-form and the other is L-form. The chiral systems are classified as three forms: the 
racemic compound, the conglomerate, and the pseudoracemate (solid solution) (Figure 
2.5). Most racemates exist in the form of racemic compound. However, only less than 
10% of racemates are conglomerate. The solid solution system seems very rare in the 
natural environment.  
 
 
Figure 2.5 Classification of the chiral system 
 
As described in Figure 2.5, for the racemic compound system, the crystals consist of a 
perfectly ordered array of R and S molecules and individual crystals contain equal 
amount of both enantiomers (both enantiomers in the same lattice). Unlike the racemic 
compound, a conglomerate consists of a mechanical mixture of crystals of the two 
enantiomers in equal amounts (different crystals of both enantiomers). The two 
enantiomers of a solid solution will coexist in an unordered manner in the crystal lattice. 
Roozeboom (1899) characterized these three fundamental chiral types by their melting 
point diagrams (Figure 2.6).  
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Figure 2.6 Binary phase diagrams of (a) conglomerate; (b) racemic compound; (c) solid 
solution: 1, ideal; 2, with a maximum; or 3, with a minimum 
 
Before the crystallization process, a valid characterization of the chiral substances is 
essential. Numerous research works focus on this topic, as a result, some amino acids has 
already been recognized and reported (Table 2.1).  
 
Table 2.1 Some reported chiral modifications of amino acids (Jacques et al., 1981) 
Conglomerate  Racemic compound Solid solution 
Homocysteine Tyrosine  
Threonine  Serine  
Asparagine  Glutamic acid  
m-tyrosine Methionine   
2-phenylglycine Phenylalanine   
 
Depending on different types of racemates, two crystallization methods, i.e., direct 
enantioselective crystallization and crystallization via diastereomeric salt formation, are 
widely applied. 
Since conglomerate racemate is simply a eutectic mixture, it can be resolved by direct 
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enantioselective crystallization, i.e., crystallization without any chiral auxiliary such as an 
enantiopure resolving agent. Sometimes, this method is also suitable for some racemic 
compound systems with a proper eutectic composition. The first experiment of chiral 
resolution was conducted by Louis Pasteur, who used the direct crystallization technique 
to separate the L- and R-tartaric acid crystals in 1849 (Flack et al, 2009). After that, this 
method was gradually developed and realized in industrial scales. For example, the (-)-
menthol, an L-α-methyldopa intermediate, and L-glutamic acid were all reported to be 
produced by direct crystallization process in industry (Lorenz et al., 2014). Shiraiwa et al. 
(1997) worked as the first one to obtain the optically active 2-amino-3-chlorobutanoic 
acid (ACB) by using the preferential crystallization technique. The ACB∙HCl exists as the 
conglomerate, and using this method could yield both enantiomers with the purity of 
80%-100%. Wermester et al. (2008) separated the R- and S-modafinic acid through the 
preferential crystallization via the AS3PC mode (auto seeded polythermic programmed 
preferential crystallization). Chaaban et al. (2013) used the continuous preferential 
crystallization to resolve the DL-asparagine monohydrate in water. As a consequence, the 
direct enantioselective crystallization can achieve low capital cost, high purity and yield, 
and simple operating process. 
As for solid solution or racemic compounds with high eutectic compostion, pure 
enantiomers cannot be obtained by direct crystallization from their equimolecular 
racemic mixture. Resolution of a racemic compound can only be realized with a chiral 
aid, usually an optically active acid or base, which cocrystallizes with the two 
enantiomers to give two diastereomeric salts. Differences in solubility and crystallization 
rate of these salts form the basis of separation by crystallization. After recovering the 
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desired diastereomeric salt, it can be decomposed to liberate the corresponding 
enantiomer by treating it with a strong acid or base. Though simple in principle, 
mechanism of chiral discrimination to form the salts is system-dependent. Various chiral 
systems were effectively resolved through this procedure. In Jourdain et al.’s paper 
(1999), the diastereomeric crystallization of (±)-mandelic- and (±)-2-(chlorophenoxy) 
propionic- acid derivatives were investigated. They chose R- or S-α-arylethylamines as 
the resolving agent and the results showed that it was a cost effective approach to 
successfully achieve the separation.
 
Phama et al. (2009) studied the chiral resolution of 
mandelic acid by using diastereomeric crystallization technique and L-phenylalanine was 
chosen as the resolving agent. Finally, they found that the L-mandelic acid was enriched 
up to 85% in the resulting products.
 
Wu et al. (2012) reported the crystallization of a pair 
of diastereomeric salts which were formed by L-/D-malic acid and L-ephedrine in water. 
L-ephedrine acted as the resolving agent and the objective was to obtain the pure L-malic 
acid. 
 
2.2.2.2 Polymorphism of amino acids 
Polymorphism is defined as the ability of a substance to crystallize in more than one 
crystalline form. Actually, polymorphs are chemically identical, but they possess different 
melting points, solubility, crystal lattice energies, dissolution rate, densities, stability, 
crystal habits, and mechanical properties. The study of polymorphism of amino acids, 
therefore, gains great importance to pharmaceutical industry, and it is a vital factor which 
should be considered in the crystallization process. A lot of factors may induce the 
occurrence of the polymorphs, for example, the temperature, the choice of solvents, the 
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crystallization conditions, the rate of precipitation, the transformation between solid 
forms, the pressure and mechanical treatment, and the absorption and release of vapor 
(Braga et al., 2009). There are diverse analytical methods to detect the appearance of 
polymorphs, most of which are easy to conduct. X-ray diffraction (XRD) on single 
crystals or powdered samples is the most widely used method to recognize the 
polymorphs due to its outstanding ability to reveal the differences in crystal structures. 
Differential scanning calorimetry (DSC) and Differential thermal analysis (DTA) are both 
effective methods to detect the polymorphs by calculating energy differences between 
polymorphs. The polymorphs also can be clearly observed by using the Scanning electron 
microscope (SEM) method. In addition, laser Raman spectroscopy, Infra- red 
spectroscopy (IR), hot stage microscopy, and solid state nuclear magnetic resonance 
spectroscopy (NMR) are all applied in this analysis (Borka et al., 1990).  
Figures 2.7-2.9 show an example of characterizing the polymorphs of glycine with 
PXRD, DSC, and photograph being applied in this research (Srinivasan et al., 2011). 
 
 
Figure 2.7 PXRD spectra of the (a) α-glycine and (b) γ-glycine crystals (Srinivasan et al., 
2011) 
 
18 
 
Figure 2.8 DSC curves of the (a) α-glycine and (b) γ-glycine crystals (Srinivasan et al., 
2011) 
 
 
Figure 2.9 Photographs of the glycine polymorphs (Srinivasan et al., 2011) 
 
2.3 Characterization of Chiral Modifications of Amino Acids 
For synthetic amino acids, usually racemic amino acids were first obtained. Resolution of 
racemic amino acids to obtain the enaniomeric pure amino acids becomes important. 
Resolution of racemic amino acids through crystallization is a powerful and efficient 
method. However, an exact characterization of the racemic modifications of amino acids 
is a prerequisite for the crystallization resolution of the racemic mixture of amino acids.  
The binary melting point phase diagram (BMP) and the ternary phase diagram (TPD) are 
the most widely used approaches to identify the recamic modification. In order to build 
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the BMP, differential scanning calorimetry (DSC) and differential thermal analysis (DTA) 
are frequently employed to test the melting point of various mixtures of enantiomers. The 
curves in the TPD should follow the similar tendency with that in the BMP. As a result, 
TPD is regarded as a convincing proof to verify the conclusion obtained in the BMP. The 
accurate solubility data should be determined to establish the TPD, so, High-performance 
liquid chromatography (HPLC) seems as the preferential choice to measure the 
concentration of mixtures in a specific solution. It can also be achieved by the Ultraviolet 
(UV) analysis or other devices. Roozeboom was the first one to distinguish the different 
types of crystalline racemates by using the phase diagrams in 1899 (Roozeboom, 1899).
 
After that, a lot of researchers applied this method in their works. For example, 
Kommuru et al. (1998) investigated the racemate and enantiomers of ketoprofen, the 
phase diagrams provided the important information about the thermodynamic studies. 
The BMP and TPD all indicated that the ketoprofen belonged to the racemic compound 
system with the eutectic point at 0.93.
 
Lorenz et al. (2002) drew the BMP and TPD of 
mandelic acid by using the TG-DSC unit and HPLC method. A eutectic point at around 
0.69 was confirmed which certify the existing of the racemic compound system (Figure 
2.10, Figure 2.11).
 
Wang et al. (2006) characterized the praziquantel by using the phase 
diagrams which were also achieved through DSC and HPLC analysis. The resulting 
phase diagrams revealed the existence of eutectic points (0.92) which demonstrated the 
racemic compound behavior of praziquantel.
 
In addition, some researchers plotted the tie 
line in the TPD, which reflected the solid liquid equilibrium and exhibited the different 
trends in conglomerate, racemic compound, and solid solution systems (Jacques et al., 
1981; Kaemmerer et al., 2007). 
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Figure 2.10 Binary melting point phase diagram of the mandelic acid (Lorenz et al., 
2002) 
 
 
Figure 2.11 Ternary (solubility) phase diagram of mandelic acid (Lorenz et al., 2002) 
 
Base on the DSC results, the eutectic points (for the racemic compound system) can be 
calculated by the Progogine-Defay equation (Eq. 2.1) and Schröder-Van Laar equation 
(Eq. 2.2). These two equations are usually combined to predict the probable eutectic 
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positions and then it will be easy to find a eutectic peak in the binary melting point phase 
diagram. Both of these equations exist for a long time but cannot be widely applied 
because of the difficulty in measuring the thermal properties. The occurrence of DSC 
technique solved this problem and could more effectively identify the chiral drugs. 
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Sometimes, the phase diagrams are not sufficient to identify the chiral substances, 
because in the experimental process, some transformations may occur. The chemicals 
may be not stable and change to another phase or decompose to other products. As a 
consequence, the additional methods need to be exploited to confirm the conclusions. 
Powder X-ray diffraction (XRD), infrared (IR), Raman spectroscopy, and 
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C solid-state 
nuclear magnetic resonance (SSNMR) spectra are all the popular techniques to compare 
the solid state spectra of enantiomers and racemates. Usually, IR and Raman work 
together and are combined as the complementary to each other. XRD is the most widely 
used method in the characterization process. All of these techniques above require small 
amount of samples and the preparation process is simple. Due to the different internal 
arrangement of three kinds of chiral systems, the spectras of the enantiomers, racemate, 
and random mixtures usually seem similar for the conglomerate and solid solution. Only 
some small shifts or the intensity difference may exist in the solid solution system. In 
turn, there will be obvious transition and shifts for the racemic compound. IR spectra and 
powder X-ray diffractograms of the different phases were described in Burger et al.’s 
paper (1997) to recognize the nitrendipine (NTD).
 
Huang et al. (2006) reported the 
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discovery of a solid solution: the chiral drug tazofelone (TZF). They also applied the 
XRD analysis in their research work. Zhang et al. (2009) applied the XRD to their work 
to demonstrate the previous results of phase diagrams. The definitely different XRD 
patterns of (R)-3-ClMA and (RS)-3-ClMA were obtained, which finally proved the 
racemic compound behavior of 3-CIMA (Figure 2.12). 
 
 
Figure 2.12 Powder XRD patterns of (R)-3-ClMA and (RS)-3-ClMA (Zhang et al., 2009) 
 
Another important approach is the single-crystal X-ray analysis which identifies the 
chiral systems from molecular structure. The intermolecular affinities between the hetero- 
and homo-chiral pairs were studied by growing and analyzing the single crystal of 
racemate and pure enantiomers. Specifically, the hydrogen bonding packing, the bond 
lengths, and the bond angles can be compared, respectively. For the racemic compound 
system, the properties above should be totally different between the racemate and 
enantiomers, however, in the solid solution or conglomerate systems, they will exhibit the 
isostructural behavior. As a consequence, the single crystal X-ray analysis is effective to 
identify the chiral drugs. An important challenge of this technique is the growing of the 
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single crystal. It is a complex and unpredictable process which may be influenced by the 
temperature, the evaporating or cooling rate, the container, the environment, the solvent, 
the specific method to obtain the crystal. As a consequence, a mass of experiments are 
needed in order to determine an optimal procedure to obtain the integrated single crystal 
(Reddy and Mehvar, 2004). Huang et al. (2006), Descamps et al. (2009), and Bredikhin et 
al. (2012) all exploited the single-crystal X-ray analysis in their works to characterize a 
kind of solid solution system.
 
They found that the structures of homo-chiral and heter-
chiral crystals are similar, which was the reason why the solid solution formed. He et al. 
(2010) investigated the crystal structures of the racemate and enantiomers of sertraline. 
The result showed that the racemate is in monoclinic P121/n1 space group and the 
enantiomers are in monoclinic P21 space group, which verified the sertraline belonged to 
the racemic compound.
 
 
2.4 Effect of Foreign Molecules on the Crystallization of Amino Acids 
In industrial scale crystallization process, the existence of impurities, which arise from 
the byproducts, additives, or other components from the environment, other than the 
targeted product, is unavoidable. Not only can it affect the kinetics of crystallization, it 
may bring some effect on the polymorphism and thermal properties.  Sometimes, only a 
few amounts of impurities may significantly influence the products of crystallization due 
to the complex interactions among diverse factors.  
 
2.4.1 Effect on the solubility 
Investigation on the effects of impurities on the solubility of targeted products is 
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important, because the driving force of crystallization process will be affected by the 
change of solubility, which will consequently influence the kinetics and polymorphs. 
Solubility data are of great technical interest due to their importance in chemical 
engineering and chemistry research. Understanding the effect of impurities on the 
solubility is necessary to proper design and control the crystallization process. Wang et al. 
(2014) discussed the effect of electrolyte impurities (NaCl, KCl, Na2SO4, and (NH4)2SO4) 
on the solubility of L-phenylalanine in aqueous solutions. It was clearly shown that the 
existence of impurities decreased the solubility of L-phenylalanine anhydrate and 
monohydrate. As a result, the electrolyte impurities could strongly affect the solubility of 
L-phenylalanine (Figure 2.13).
 
 
 
Figure 2.13 Mole fraction solubility of L-phenylalanine anhydrate from 293.00 to 308.00 
K and monohydrate from 312.00 to 328.00 K in pure water and aqueous solution in the 
presence of four salts: ◆,pure water; ▲, potassium chloride; ■, sodium sulfate; 
●,ammonium sulfate; −, sodium chloride (Wang et al., 2014) 
 
Generally, the influencing mechanism of impurities on the solubility can be understood 
from two aspects: the effects of electrolyte impurities and the tailor-made additives. For 
the electrolyte impurities, it is difficult to interpret and predict the effect on crystal 
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polymorphs. The ions may form an ordered adsorption layer at the interface or change the 
solution environment. Ions can be selectively incorporated into the different faces, for 
instance, the Cr
3+
 and Fe
3+
 are more easily incorporated into (100) than into (101) faces 
(Dhanaraj et al., 2010), thus the solubility will change with the changing of stability. For 
the tailor-made impurities, which refer to molecules that share similar molecular structure 
to the solute with only slight structural variations, it becomes easier to adsorb to the 
crystal lattice and in this way changes the solubility of solute.  
 
2.4.2 Effect on the nucleation 
It is well known that both crystal nucleation and crystal growth are involved in the 
crystallization. Nucleation can be artificially induced or occur spontaneously. The 
primary nucleation rate is usually described as the Equation 2.3 below (Mullin, 2001). 
𝐽 = 𝐴𝑒𝑥𝑝[−
16𝜋𝛾3𝑣2
3𝑘3𝑇3(𝑙𝑛𝑆)2
]                                                                                                 (2.3) 
The impurities can affect the induction time thus affect the nucleation process, whereas it 
is difficult to find a general explanation and prediction for the influencing mechanism of 
various impurities. According to a specific pair of solution and impurity, the effect and 
changing tendency should be independently studied. The attenuated total 
reflection−Fourier transform infrared (ATR-FTIR) and focused beam reflectance 
monitoring (FBRM) are most frequently used techniques to measure the nucleation 
kinetics, and this process can also be recorded by some off-line observations. During the 
past years, a lot of works have been done in this area and some useful experience and 
suggestions were provided. For example, as most researchers reported, some foreign ions, 
such as Cr
3+
, Fe
3+
, Al
3+
, Ni
2+
, Na
+
 possess a strong inhibiting effect on the inorganic salts, 
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but the effect becomes complex in the organic systems. Wang et al. (2007) tested the 
effect of ionic impurities on the crystallization of phosphoric acid hemihydrates and also 
observed the whole process by using the FBRM. They found that the crystal nucleation 
rate was suppressed due to the presence of Fe
3+
, Al
3+
, and F
- 
, which was opposite in case 
of adding some small amounts of H2SO4. Chen et al. (2010) investigated the influence of 
ionic impurities on the crystallization of cobalamine by using the FBRM. In their work, 
the Mg
2+
, Ca
2+
, and Fe
3+
 acted as the impurities and the results showed that the Mg
2+ 
made the induction time shorter and thus promote the crystal nucleation, however, the 
Ca
2+
, and Fe
3+ 
extended the induction time because they decreased the degree of 
supersaturation.  
Despite of the ionic impurities, some organic substances also perform as the impurities in 
the crystallization process. In most situations, these impurities have the similar structures 
with the targeted products. Ottens et al. (2004) investigated the effect of phenylglycine 
and 6-aminopenicillanic acid on the crystallization of ampicillin (AMPI). Phenylglycine 
and 6-aminopenicillanic acid were the building blocks of AMPI, which was commonly 
tested in the AMPI production process. They made a conclusion that these two impurities 
would slower the nucleation rate. Markande et al. (2012) studied the crystallization of 
dextrose monohydrate, and the syrup was regarded as the impurity. The kinetics was 
studied using in-line focused FBRM technique. It turned out that the nucleation rate was 
enhanced by the presence of the small amount of impurity. 
Another suggestion is that when the impurities inhibit the primary nucleation process (the 
spontaneous birth of crystals), the secondary nucleation may be enhanced. Specifically, 
the impurities can be adsorbed at defects on the existing crystal surfaces, initiate the 
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crack propagation, or induce the crystal disintegration (Mullin, 2001). 
 
2.4.3 Effect on the crystal growth 
The crystal growth will be affected through the incorporation of the impurities into the 
crystal lattice or the adsorption of impurities at the surface of the crystal. In this way, the 
growth in some directions will be suppressed, and in turn, the growth rate will be higher 
in other directions. The structure and size of crystals can be consequently changed. This 
phenomenon can be investigated by measuring the micro-images of the crystals or 
monitoring the concentration of the mother liquor. Some impurities can inhibit growth; 
some can enhance growth; some impurities make effects at very low concentrations, 
while others may only affect growth at high-level concentrations. This process is complex 
because of the diverse reasons for the rate change. The growth rate can be changed by the 
impurities in the following ways: changing the properties of the solution, changing the 
supersaturation, changing the equilibrium concentration (Mullin, 2001). 
The commonly used expression of growth rate is as below: 
𝐺 = 𝐾𝐺∆𝑐
𝑔                                                                                                                    (2.4) 
Some researches focus on the inhibit effect are as follows. In Ottens et al.’s (2004) paper, 
the impact of phenylglycine and 6-aminopenicillanic acid on the crystallization kinetics 
of ampicillin (AMPI) was reported. These two kinds of impurities are the building blocks 
of AMPI, so they would always exist in any AMPI manufacturing process. They applied 
the single crystal growth rate analysis method to determine the growth rate of AMPI, and 
the results showed that the impurities could retard the nucleation and growth process. 
They interpreted this phenomenon by the decreased space and increased Gibbs energy 
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barrier for AMPI adsorption and incorporation because of the adsorption of impurities at 
the AMPI crystal surface. Chen et al. (2010) revealed the affecting mechanism of some 
ionic impurities on the crystallization of cobalamine. The FBRM method and scanning 
electron microscope (SEM) were applied to analyze the impurity effect on the crystal 
growth process. The result showed that Mg
2+
 could slower the growth rate. It was 
because that the adding of Mg
2+
 could increase the supersaturation degree, as a result, 
both the solubility and metastable zone width changed. Markande et al. (2012) studied 
the influence of syrup on the crystallization of dextrone monohydrate. The crystal growth 
rate was simulated by the moment model and the mass balance equation, and the relevant 
concentration data were monitored by the FBRM. Finally, they demonstrated that the 
growth rate became lower with the increasing concentration of the impurities. This 
phenomenon stemmed from the adsorption of syrup onto the crystal surface, which 
produced a higher energy barrier and meanwhile left less space for the dextrose. Mazzotti 
et al.
 
(2013) investigated the influence of R-mandelic acid on the growth kinetics of S-
mandelic acid in aqueous solutions, in which the R-mandelic acid was regarded as the 
impurity. The researchers concluded that the presence of R-mandelic acid could lower the 
growth rate and blemish product purity of S-mandelic acid. This effect was mainly 
because of the competitive adsorption of the R-mandelic acid on the crystal surface of S-
mandelic acid, which was demonstrated by the result obtained through molecular 
modeling.  
On the other hand, some positive effects were reported and analyzed. Lee et al. (2007) 
studied the effect of (S)-(+)-Ibuprofen and (S)-(-)-Sodium Ibuprofen Dihydrate on the 
crystallization kinetics of racemic (R,S)-(±)-Sodium Ibuprofen Dihydrate by applying the 
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electrical conductance, optical microscopy, differential scanning calorimetry, and wide 
angle powder X-ray diffraction methods. The results indicated that the nucleation and 
growth rate increased when the homochiral impurities were added. According to the 
induction time and Gibbs energetic barrier values, it became easier to understand that the 
nucleation and growth were promoted because of the significant decrease in the Gibbs 
free-energy barrier on the presence of the configurationally similar impurities. Yang et al. 
(2013) investigated the effect of L-valine on L-alanine crystal growth by combining 
single-crystal growth experiments and molecular simulation. They concluded that at high 
L-valine concentrations, the growth of L-alanine will be eventually promoted. It could be 
explained that normally the L-alanine will easily form the hydrogen bonds with H2O 
molecules which may limit the surface mobility, and then retard the growth. The 
existence of L-valine disrupted this kind of combination and changed the L-alanine to 
repel H2O molecules. In this way, the growth rate was increased at the presence of 
impurity.  
 
2.4.4 Effect on the polymorphism 
Sometimes the impurities may modify the crystal habit and thus induce the occurrence of 
polymorphs. Therefore, the final crystal morphology can be controlled and manipulated 
by adding a certain amount of tailor-made additives. As discussed in the last section, the 
impurities can be adsorbed onto the crystal surface and then block the sites which belong 
to the targeted products. During this process, the growth in some directions will be 
enhanced or restrained, which provide the possibility of the appearance of polymorphs. 
Cashell et al. (2005) mainly investigated the effect of additives on the polymorphism of 
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glutamic acid. L-phenylalanine and L-tyrosine were chosen as the impurities. The results 
indicated that different ratios of impurities and solute would induce different polymorphs. 
When the molar ratio of impurity/L-glutamic acid was 1:30, a stable α-form could be 
obtained. When the impurity ratio increased to 1:6, the β-form was achieved. The SEM 
images clearly exhibited this transformation was shown in Figure 2.14.
 
Poornachary et al. 
(2008) studied the influence of some byproducts on the crystallization of N-
phosphonomethyl glycine (PMG). The impurities included the iminobismethylene 
phosphonic acid (IMPA), the amino methyl phosphonic acid (AMPA), and the N-
phosphonomethyl imino diacetic acid (PIDA). They found that the IMPA and AMPA 
could be incorporated into PMG crystals by selectively adsorbing onto the (100) face. As 
a result, the growth rate would be lower for this face of the crystal which leaded to the 
appearance of polymorphs.  The PIDA had no significant effect on the modification of the 
crystal habit because of a lower binding affinity to PMG crystals. The micro images of 
these different products were shown in Figure 2.15. In Kuvadia et al.’s (2013) work, a 
mechanistic model was developed which could predict the crystal morphology in the 
presence of the structurally similar additives. Quantitative estimation of imposter 
recognition on each crystal face was carried out in this study using a combination of 
mean field theory and configurational energy minimization. The mechanistic effect of an 
impurity on the crystal growth rate and crystal habits was computed on the basis of 
imposter recognition. Their model provided good predictions on the experimental 
morphologies of α-glycine with L-alanine impurity and paracetamol with p-
acetoxyacetanilide impurity grown from water (Figure 2.16).  
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Figure 2.14 Electron micrographs of L-Glu crystallized with L-Phe: (a) no additive, (b,c) 
1×10
-2 
M; (d) 2×10
-2
 M. (L-Glu= 0.3 M) (Cashell et al., 2005) 
 
 
Figure 2.15 PMG crystallized from pure solution (a) and from impurity-doped solutions 
(1.0 wt% on PMG): (b) IMPA, (c) AMPA, and (d) PIDA (Poornachary et al., 2008) 
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Figure 2.16 Four different positions for the imposter L-Alanine to replace glycine 
molecules and form dimers within the unit cell (Kuvadia et al., 2013) 
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Chapter 3 Solid Tryptophan as a Pseudoracemate: Physicochemical and 
Crystallographic Characterization
1
 
 
1
 A version of this chapter has already been published online. 
Li Y., Y.M. Zhao, Y. Zhang. Solid tryptophan as a pseudoracemate: physicochemical and 
crystallographic characterization. Chirality 2014; doi: 10.1002/chir.22399 
 
3.1 Introduction 
The demand for enantiopure substances, foremost by pharmaceutical and food industries, 
continues to increase due to the heightened awareness that enantiomers of a racemic 
mixture may have different pharmacological effects on humans. Separation of 
synthetically produced racemates is by far the dominant method to obtain enantiopure 
chemicals (Subramanian et al., 2001).
 
Among various enantioseparation methods, 
resolution through crystallization has proved to be simple and efficient. Generally 
speaking, crystallization from a racemic solution results in one of the three possible 
outcomes: a conglomerate, a racemic compound, or a pseudoracemate (solid solution) 
(Jacques et al., 1981; Stahly et al., 1999; Zhang et al., 2003).
 
A conglomerate is a 
physical mixture of the pair of enantiomer crystals, constituting 5–10% of the organic 
racemates (Takiyama et al., 2002; Sapoundjiev et al., 2006). A solid racemic compound 
is the most common type of racemates, which consists of an even ratio (1:1) of both 
enantiomers in a regularly structured array (Worlitschek et al., 2004; Zhang et al., 2009).
 
A pseudoracemate or a solid solution forms when the two enantiomers co-exist in an 
unordered manner in the crystal. The formation of a pseudoracemate over the entire range 
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of composition (0 < x < 1) is very rare (Bredikhin et al., 2012; Balawejdera et al., 2013). 
Depending on the type of racemates, two crystallization methods, namely direct 
crystallization (Jacques et al., 1981)
 
and crystallization via diastereomeric salt formation 
(Kozma, 2001) are widely used for chiral resolution. Theoretically, pure enantiomers can 
be obtained through preferential crystallization of conglomerate-forming systems or 
compound-forming systems with one enantiomer present in a sufficient enantiomeric 
excess (Lorenz et al., 2006; Zhang et al., 2010; Codan et al., 2013).
 
For pseudoracemates, 
pure enantiomer cannot be obtained by preferential crystallization, although enrichment 
of one enantiomer is attainable for Type II and Type III solid solution systems as 
demonstrated in Figure 3.1. Complete separation of pseudoracemates has to rely on 
indirect crystallization by adding resolving agents to form diastereoisomers, followed by 
fractional crystallization. Therefore, solid-state characterization of racemates is essential 
for the development of proper crystallization methods of chiral resolution. 
Binary melting-point phase (BMP) diagram and ternary solubility diagram are frequently 
exploited to identify the racemic modification of a certain chiral system. A BMP diagram 
is usually determined through the measurement of melting points of mixtures of known 
enantiomeric composition by differential scanning calorimetry (DSC) (Lorenz et al., 
2004; Li et al., 1999).
 
However, in some cases, examination of BMP alone may not be 
adequate to distinguish between the various racemic modifications; in particular, when 
the racemate exists either as a metastable racemic compound or as a metastable racemic 
conglomerate (Li et al., 1999; Tabora et al., 2007). Ternary phase diagram (TPD) is 
obtainable from the isothermal measurement of solubility of enantiomeric mixtures in a 
liquid solvent (Jacques et al., 1981; Klussmann et al., 2006). Knowledge of solubility 
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properties of enantiomeric mixtures can provide more accurate prediction on the 
prevailing solid state of racemates. 
 
 
 
 
Figure 3.1 Melting point phase diagrams for pseudoracemates: Type I-ideal solution; 
Type II-solution with maximum melting temperature; Type III- solution with minimum 
melting temperature 
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Structural characterization of racemic modification is usually performed by studying 
either the single crystal X-ray structures or the powder X-ray diffraction (XRD) patterns 
of racemates and pure enantiomers (Huang et al., 2006; De Diego et al., 2011). The 
difference in the intermolecular forces between the hetero- and homo-chiral pairs helps to 
characterize the racemic modifications (Jacques et al., 1981). In a conglomerate each 
enantiomer has a greater affinity for molecules of its own kind than for the opposite 
enantiomer, and the two enantiomers crystallize in separate phases. On the contrary, in a 
racemic compound each enantiomer has a greater affinity for molecules of the opposite 
type than for its own kind. The unit cell of the crystal of racemic compound thus contains 
an equal number of molecules of each enantiomer, and the product is a true addition 
compound. In cases where there is only small difference in the affinity between homo-
chiral and hetero-chiral pairs, modification shows nearly ideal mixing and forms a 
racemic solid solution (Jacques et al., 1981; Gu et al., 2004).
 
In terms of powder XRD 
patterns, a conglomerate has the same pattern as that of pure enantiomer(s), whereas the 
pattern of a racemic compound is quite distinct from that of pure enantiomer(s). The 
powder XRD pattern of a pseudoracemate shares almost identical Bragg peaks to that of 
pure enantiomer(s), while slight changes in intensity and width or shift of characteristic 
peaks may occur (Gu et al., 2004).
 
This study reports the physicochemical and structural characterization of solid-state 
tryptophan. Tryptophan is one of the 22 standard amino acids essential to humans. 
Tryptophan molecule has one stereogenic center at the carbon connecting the carboxylic 
acid and amino groups. Hence there are two optical isomers, namely D- and L-tryptophan 
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(Figure 3.2). Only L-tryptophan (L-Try) can be naturally found in animal and plant 
proteins. L-Try is important in helping human body create vitamin B-3 and the hormone 
melatonin. It also plays an important role in regulating mood, sleep cycles, and the 
perception of pain (Schneider-Helmet et al., 1986). In addition, L-Try has also shown 
some promise as an antidepressant alone and as an "augmenter" of antidepressant drugs 
(Thomson et al., 1982).
 
In contrast, D-tryptophan (D-Try) does not show any biological 
functions and is mainly used as a pharmaceutical intermediate (Dong et al., 2011).
 
Characterization of the solid-state properties of tryptophan system is therefore of 
significant importance, as the knowledge provide guidance to establish cost-effective 
methods to isolate enantiopure D- and L-Try from the synthetic racemic tryptophan (DL-
Try). 
 
 
Figure 3.2 Molecular structures of D- and L-tryptophan 
 
In this work, we have investigated the thermochemical and structural properties of 
various binary mixtures of tryptophan by DSC, solubility measurement, single-crystal 
and powder X-ray diffraction analyses. All the results indicate that tryptophan system 
exists in the form of pseudoracemate over the entire range of enantiomeric composition. 
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To the best of our knowledge, this is the first comprehensive study on the 
physicochemical and structural properties of solid tryptophan. The important contribution 
of this work lies in the finding that the intermolecular interactions in the solid state of 
racemic tryptophan (DL-Try) are very similar to the motifs in pure enantiomers (L-Try). 
This observation helps to gain in-depth understanding on why elucidation of the detailed 
solid-state structure for pure enantiomers of tryptophan has been so challenging. 
 
3.2 Materials and Methods 
3.2.1 Materials 
DL-Try (98%) and L-Try (99%) were purchased from Fisher Scientific, Canada. Prior to 
any characterization, the solid phases were purified by recrystallization. Reagent grade 
methanol and isopropyl alcohol (IPA), purchased from Fisher and ultrapure water 
generated from the Milli-Q Integral 5 system (Millipore, Billerica, MA, US) were used as 
the solvent. Sodium dihydrogen phosphate (99%), disodium hydrogen phosphate (99%) 
and HPLC grade 1-proponal (99.9%) were purchased from Sigma-Aldrich, Canada for 
HPLC analysis. 
 
3.2.2 Differential scanning calorimetry 
DSC measurement was carried out on a Mettler Toledo DSC 1 system (Mettler Toledo, 
Canada). The DSC curves were recorded and analyzed using the STAR
e
 software. Before 
testing the samples, the calorimeter was calibrated using indium standard. For 
quantitative analysis, the enantiomeric mixtures were prepared by mechanical mixing of 
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DL- and L-Try using mortar and pestle. Enantiomeric mixtures with mass fractions of L-
Try being 0.50, 0.54, 0.60, 0.70, 0.80, 0.85, 0.88, 0.90, 0.91, 0.92, 0.95, and 1.00 
respectively were prepared for DSC analysis. Samples were sealed in aluminum 
crucibles. All DSC scans were performed from 100 °C to 350 °C at a heating rate of 10 
°C/min with nitrogen being used as the purge gas. The measurements were duplicated for 
DL- and L-Try to ensure reliable reproducibility (relative error < 2%). 
 
3.2.3 Solubility measurement  
Solubility of eight enantiomeric mixtures of DL- and L-Try was measured at 20°C. Mass 
fractions of L-Try in these eight samples were set at 0.50, 0.60, 0.70, 0.80, 0.85, 0.90, 
0.95, and 1.00 respectively. Water/IPA mixture was used as solvent (molar fraction of 
IPA is 0.194). A certain amount of sample of known enantiomeric composition was 
added to 50mL of solvent in a 100 mL jacketed glass crystallizer. The solution was 
continuously agitated by a magnetic stirrer. The temperature of solution was controlled 
using a programmable Julabo FP50 heating/cooling circulator (Allentown, PA, US). 
Solute was added gradually into the crystallizer until a supersaturated solution was 
attained and the supersaturated solution was stirred over 24 hours at 20°C. Afterwards, 
samples of saturated solutions were taken from the supernatants with syringes equipped 
with filters (45μm pore size) and analyzed subsequently by HPLC. The crystals were 
dried and the corresponding compositions were determined through HPLC analysis. 
Agilent 1100 series HPLC system (Agilent Technologies, Canada) equipped with a 4.6 × 
150 mm Resolvosil BSA-7 chiral column (Macherey-Nagel, Germany) was used to 
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determine the concentration of D- and L-Try in sample solutions. The mobile phase was 
50mM phosphate water solution of pH7.0, containing 2.0 vol% of 1-propoanl. HPLC 
analyses were performed at 25  0.1 °C with the elution flow rate of 0.7 mL/min. A diode 
array detector was used for the analysis and the detection wavelength was set at 225 nm. 
 
3.2.4 Powder X-ray diffraction 
Powder XRD patterns of DL- and L-Try and two mixtures of them were measured by a 
Rigaku Ultima-IVX-ray diffractometer with a Cu X-ray source and a scintillation 
detector at room temperature. Sample was mounted on an Al sample holder and scanned 
from a diffraction angle (2θ) of 5° to 80° with a step size of 0.02° and a counting time of 
1s for each step. The methods were validated for accuracy and precision. Reproducibility 
of the results was checked by recording the spectra of DL-Try twice. Data were 
processed using the software of MDI-Jade version 9. 
 
3.2.5 Single-crystal growth and structure determination 
Single crystals of DL-Try were grown from a concentrated solution of DL-Try in 
water/methanol mixture by slow evaporation at room temperature. The single crystal X-
ray diffraction data of DL-Try were collected on a Rigaku AFC8-Saturn 70 single crystal 
X-ray diffractometer (MoKα radiation), equipped with an X-Stream 2000 low 
temperature system and a SHINE optic. For low temperature collection, colorless crystal 
with dimensions of 0.23 × 0.1 × 0.04mm was mounted on a glass fiber. Routine structure 
determination and refinement were performed using the SHELXS-2008 and SHELXL-
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2008 software packages (Sheldrick et al., 2008).
 
Visualization and diagram production 
were undertaken using Mercury (Mercury, 2001-2013). 
The single crystal structure of L-Try has been recently reported (Gorbitz et al., 2012).
 
Single crystal X-ray diffraction data for L-Try was obtained free of charge from the IUCr 
electronic archives (Reference: EB5018).  
 
3.3 Results and Discussion 
3.3.1 Absence of eutectic melting  
Figure 3.3 shows the DSC melting curves for the solid samples of tryptophan with 
various mass fractions of L-Try (0.5 ≤ x ≤ 1.0). As anticipated, DL- and L-Try give a 
single peak and the racemate melts at a higher temperature than the pure enantiomer. It 
has been known that the Gibbs free energy of recamate formation is always negative 
(ΔG° < 0) when the racemate melts at a higher temperature than the pure enantiomer 
(Jacques et al., 1981; Tabora et al., 2007), suggesting that the formation of a racemic 
compound or a pseudoracemate is thermodynamically favored for this system. Therefore, 
solid tryptophan cannot be a conglomerate. As two peaks are present in the DSC curves 
during the melting of enantiomeric mixtures (0.5 < x < 1.0) for racemic compounds and 
pseudoracemates of Types II and III, the onset of fusion can be employed to differentiate 
a pseudoracemate from a racemic compound. In the latter case, the onset of fusion occurs 
at the eutectic temperature, which is lower than the melting points of both pure 
enantiomer and racemic compound. However, tryptophan mixtures always melt at a 
temperature higher than that of pure L-Try as seen from Figure 3.3, which is a clear 
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indicative of the absence of eutectic melting for this system. 
 
 
Figure 3.3 DSC curves of tryptophan with various mass fraction of L-Try 
 
To confirm the absence of eutectic melting of tryptophan system, eutectic composition 
( eu
x
) and eutectic fusion temperature (
f
euT ) were calculated by solving the Progogine-
Defay equation (Eq. 3.1) and Schröder-Van Laar equation (Eq. 3.2) simultaneously using 
the measured thermal properties of DL-Try and L-Try.  
ln 4𝑥(1 − 𝑥) =
2∆ℎ𝑅
𝑓
𝑅
(
1
𝑇𝑅
𝑓 −
1
𝑇𝑓
)                                                                                       (3.1) 
ln 𝑥 =
∆ℎ𝐴
𝑓
𝑅
(
1
𝑇𝐴
𝑓 −
1
𝑇𝑓
)                                                                                                       (3.2) 
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where 
f
Ah (83.3 kJ/mol) and 
f
Rh (108.0 kJ/mol) are the enthalpies of fusion for L-Try 
and DL-Try; 
f
AT (291.6 °C) and 
f
RT (302.06 °C) are the melting temperatures of L-Try 
and DL-Try respectively; R is the gas constant. 
The calculation gives the eutectic composition and eutectic fusion as xeu = 0.909, and 
f
euT
= 288.34 °C. To verify the calculated results, additional DSC measurements were 
undertaken on mixtures with mass fractions of L-Try close to the calculated xeu. Once 
again all the DSC curves in Figure 3.4 show two melting peaks with the onset melting 
temperature very close to that of L-Try, corroborating the absence of eutectic melting. 
 
Figure 3.4 DSC curves of enantiomeric mixtures with mass fraction of L-Try identical or 
close to the calculated eutectic composition 
 
The BMP diagram of enantiomeric tryptophan system was constructed based on DSC 
melting endotherms as presented in Figure 3.5. No eutectics are observed in the phase 
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diagram and the appearance of this BMP diagram is characteristic of a pseudoracemate 
with a maximum melting point (Balawejdera et al., 2013).
 
However, pseudoracemates 
with maximum melting are very rare, it is premature to draw the conclusion that 
enantiomeric tryptophan is a pseudoracemate simply based on the result of BMP. For 
more conclusive evidence, other characterization methods have been employed to verify 
the observation from the BMP diagram and to provide deeper insight into the interactions 
of D- and L-Try. 
 
Figure 3.5 Binary melting point diagram of tryptophan system 
 
3.3.2 Ternary solid-liquid equilibria 
Solubility of the enantiomeric mixtures of tryptophan with mass fractions of L-Try 
between 0.50 and 1.00 in water/IPA (molar fraction of IPA is 0.194) was measured at T = 
20 °C. Results of solubility measurement are listed in Table 3.1. Ternary solubility 
diagram for tryptophan system is illustrated in Figure 3.6. As seen from Table 3.1 and 
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Figure 3.6, the solubility of L-Try is the highest while the solubility of DL-Try is the 
lowest. Solubility of enantiomeric mixtures (0.5 ≤ x ≤ 1.0) increases continuously with 
increasing mass fraction of L-Try in the mixture. This result confirms the absence of 
eutectic composition from the system. It is known that the enantiomeric mixture with 
eutectic composition has the highest solubility (Jacques et al., 1981; Mason et al., 1982). 
For a conglomerate forming system, the eutectic composition is 0.5, which means that 
racemate has the highest solubility. For a compound forming system, the eutectic 
composition is expected to be between the racemate and the enantiomer, i.e., 0.5 
<xeu<1.0, indicating that neither the racemate nor the enantiomer has the highest 
solubility. However, in the case of tryptophan, pure enantiomer of L-Try shows the 
highest solubility, suggesting the formation of Type II pseudoracemate in this system. 
Different enantiomeric compositions of the saturated liquid solutions and the solids in the 
measured SLE data listed in Table 3.1 further confirm the formation of Type II 
pseudoracemate for tryptophan system. It is clearly seen from Table 1 that for all ternary 
systems containing enantiomeric mixtures with 0.5 < xL < 1.0, xL values of the remaining 
solids decrease while xL of their equilibrium liquids increases slightly. Therefore, the 
obtained tie lines in TPD have greater slopes than the lines passing though points S (apex 
repenting pure solvent) and M (mixing points of ternary system). Measured SLE of 
ternary tryptophan system is completely consistent with that of Type II pseudoracemate 
system (Jacques et al., 1981).      
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Table 3.1 Solubility of the enantiomeric mixtures of tryptophany at T=20°C 
xL* 
of initial mixture 
Solubility 
g/L 
xL 
of saturated liquid 
xL 
of the solid 
0.5 (DL-Try) 1.96 0.5 0.5 
0.6 2.00 0.619 0.561 
0.701 2.11 0.715 0.639 
0.802 2.46 0.814 0.737 
0.85 2.64 0.861 0.763 
0.902 3.31 0.912 0.839 
0.949 4.09 0.951 0.915 
1.0 (L-Try) 10.62 1.0 1.0 
* xL represents the mass fraction of L-Try in the enantiomer mixtures of tryptophan; xL 
values listed in this table were determined by chiral HPLC analysis. 
 
 
Figure 3.6 Ternary phase diagram of tryptophan system in H2O/IPA 
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3.3.3 Powder X-ray diffraction 
Further evidence for solid tryptophan being a pseudoracemate was attained from powder 
XRD studies. Diffractograms of DL-Try, L-Try and two enantiomeric mixtures 
containing 70 wt% and 90 wt% of L-Try were compared in Figure 3.7. It can be seen that 
all these compounds give very similar powder XRD patterns; in particular, the diffraction 
angles of most the important peaks and the overall trend are almost the same. There are 
no significant differences or notable shifts among the four XRD profiles, which 
convincingly rule out the possibility of a racemic compound. On the other hand, slight 
variations in peak intensity and diffraction angle are still noticeable in Figure 3.7. 
Moreover, peak resolution at higher angles is poor in the racemate diffractograms (DL-
Try) as compared with the enantiomer diffractograms (L-Try). Hence, this system is not 
recognized as a conglomerate. Powder XRD results confirm the formation of a 
pseudoracemate for tryptophan system, which is in agreement with the results of BMP 
and ternary solubility diagram. 
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Figure 3.7 Powder XRD patterns of tryptophan with various mass fraction of L-Try 
(Variations in peak intensity and diffraction angle are indicated by an asterisk) 
 
3.3.4 Single crystal structures of DL- and L-Try 
Relatively few examples of pseudoracemates are known in the literature and even fewer 
have been subjected to structural investigations (Bredikhin et al., 2012; De Diego et al., 
2011; Descamps et al., 2009; Brandel et al., 2013). It is evident from the binary and 
ternary phase diagrams that enantiomeric mixtures of tryptophan form a solid solution 
over the entire range of composition. In this section we attempt to disclose the underlying 
mechanism from the perspectives of the intermolecular affinities between the hetero- and 
homo-chiral pairs by examining the crystal structure data of DL- and L-Try. 
The lattice parameters of DL-Try obtained from the current study** are compared with 
those reported for L-Try (Gorbitz et al., 2012).
 
Detailed crystal structure data of DL- and 
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L-Try are summarized in Table 3.2. As shown in Table 3.2, single crystal of DL-Try 
belongs to P21/c space group with Z = 4, whereas L-Try crystallizes to P1 space group, a 
subgroup of P21/c with Z = 16. This observation coincides with a rule proposed by 
Jacques et al. (1981) based on statistical surveys of pseudoracemates; that is, the 
enantiomer space group is always a subgroup of that of the racemate.
 
 
Table 3.2 Crystal structure data of DL-Try and L-Try 
 DL-Try L-Try
a
 
Chemical formula  C11H12N2O2 C11H12N2O2 
Molecular weight  204.23 204.23 
Temperature, K 143.15 123 
Crystal system, space group  Monoclinic,P21/c Triclinic, P1 
Unit Cell 
a,Å 18.981 11.43 
b,Å 5.782 11.464 
c,Å 9.348 35.606 
α, ° 90 84.421 
β, ° 101.695 87.694 
γ, ° 90 60.102 
V,Å
3
 1004.5 4025.3 
μ, mm-1 0.095 0.095 
D, g/cm
3
 1.35 1.348 
Z 4 16 
a
Crystal structure data of L-Try are extracted from the work of Görbitz et al. (2012) 
Crystallographic data for DL-Try reported in this paper have been deposited 
with the Cambridge Crystallographic Data Centre (CCDC # 997182). 
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Figure 3.8 (a) ORTEP plot of D-Try at 50% probability ellipsoids with atomic 
numbering. (b)  Four molecules in the unit cell of DL-Try 
 
The unit cell and the numbering of atoms of DL-Try are demonstrated in Figure 3.8. Two 
pairs of D- and L-Try molecules are packed in one crystal unit cell of DL-Try to form the 
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racemate. All DL-Try molecules have the same conformation with torsion angles of N2-
C10-C9-C7 (χ1) and C10-C9-C7-C8 (χ2) being -166.8° and -108.4° respectively. As for 
L-Try, two molecular conformations have been found in the unit cell according to the 
work of Görbitz et al. (2012). Eight molecules show very close conformation of DL-Try 
with average torsion angles of χ1 = -173.4° and χ2 = -113.8°. The other eight molecules 
have a different conformation with average torsion angles of χ1 = -79.0° and χ2 = 111.6°. 
Although significant differences in the conformation of the molecular structures have 
been found between DL- and L-Try (Bakke et al., 1980; Hubschle et al., 2004), the 
hydrogen bond packing of DL-Try resembles that of L-Try as illustrated in Figure 3.9. As 
seen from Figure 3.9a, the protonated amino group acts as the donor of three hydrogen 
bonds in the crystal packing. The #2 hydrogen bond (N1 – H2B ∙∙∙ O1) is formed via the 
crystallographic inversion center so that the racemic compound forms a DL-dimer. The 
other two N– H ∙∙∙ O hydrogen bonds link these dimers to form a two dimensional 
network which results in a head-to-head bilayer arrangement of the molecules. A notable 
feature of hydrogen bonding packing in L-Try is that molecules with identical 
conformations occur in pairs along a series of repeating units. A two dimensional 
network of hydrogen bonds of L-Try, similar to that of DL-Try is illustrated in Figure 
3.9b.  
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Figure 3.9 Hydrogen bonding packing of (a) DL-Try and (b) L-Try (The numbers 
identify three types of hydrogen bonds) 
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The hydrogen bond lengths and bond angles in the crystal structures of DL- and L-Try 
are compared in Table 3.3. Hydrogen bond lengths and angles in the crystal structure of 
DL-Try are quite close to those of L-Try except for a slightly shorter length of #2 bond of 
DL-Try. In addition, nitrogen in the indole ring of tryptophan acts as a donor to give the 
N – H ∙∙∙ π interactions between the hydrogen and the phenyl ring. The representative 
lengths of the two shortest N – H ∙∙∙ C(π) interactions of DL-Try are illustrated and 
compared with those of L-Try in Figure 3.10. Not surprisingly, the two shortest N – H ∙∙∙ 
C(π) interactions of DL- and L-Try are also very close in geometry to each other. It is 
therefore reasonable to assume that hetero- and homo-chiral pairs of tryptophan would 
exhibit nearly identical solid-state packing and intermolecular forces. These resembling 
intermolecular forces lead to the formation of pseudoracemate for solid tryptophan.     
 
Table 3.3 Geometric characteristics of hydrogen bonds in the crystal structures of DL- 
and L-Try (distance in Å, angle in °) 
D ˗˗ H ∙∙∙ A d(D-H) d(H∙∙∙A) d(D∙∙∙A)  (DHA) 
DL-Try
a
 
N2 ˗˗ H2A ∙∙∙ O1 #1c 0.89 1.98 2.84 164.2 
N2 ˗˗ H2B ∙∙∙ O1 #2 0.89 1.94 2.83 171.4 
N2 ˗˗ H2C ∙∙∙ O2 #3 0.89 1.84 2.72 170.9 
L-Try
b
 
N1 ˗˗ H1 ∙∙∙ O1 #1 0.91 1.94 2.80 159 
N1 ˗˗ H3 ∙∙∙ O1 #2 0.91 2.0 2.90 171 
N1 ˗˗ H2 ∙∙∙ O2 #3 0.91 1.82 2.71 167 
a
Symmetry: #1:-x, ½+y, ½-z; #2: -x, 1-y, 1-z; #3: x, -1+y, z. 
b 
Data of L-Try are extracted from the work of Görbitz et al. (2012). Bond lengths and 
angles listed for L-Try are the average values for 16 interactions. 
c
 Types of hydrogen bonds as indicated in Fig. 9. 
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Fig 3.10 Comparison of the N – H ∙∙∙ π hydrogen bond of (a) DL-Try and (b) L-Try  
 
3.4 Conclusions 
Racemic modification of solid tryptophan has been examined by physicochemical 
characterization and X-ray structural analyses. Results from binary melting point diagram 
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and ternary solubility diagram indicate that the tryptophan system is pseudoracemate, 
which is further confirmed by powder XRD and single crystal structure data. 
Comparative studies on the single crystal structures of DL-Try and L-Try have revealed 
two important factors accounting for the formation of tryptophan pseudoracemate. First, 
the hydrogen bond geometries and forces in the solid-state structures of racemic and pure 
tryptophan enantiomers are almost the same. Second, two symmetry independent 
molecules exist in the unit cell of L-Try single crystal, with one conformation very close 
to the solitary conformation of DL-Try. As a result, molecules in the enantiomeric 
crystalline lattice can be easily replaced by the opposite enantiomer, leading to 
transformation of enantiomeric crystal into racemate crystal. 
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Chapter 4 Effects of Structure Similar Additive on the Crystallization of 
L-Phenylalanine from Aqueous Solution 
 
4.1 Introduction 
The investigation on the effects of impurities has a significant impact on the study of 
crystallization processes. Specifically, impurities could ultimately lead to kinetic or 
morphological changes, which may affect the operating efficiency and the purity of the 
final products. For the kinetic influence, the impurities, such as byproducts, degraded 
products, additives and other foreign components may affect the nucleation as well as the 
growth process (Ottens et al., 2004). Different amounts of impurities may affect the rate 
of crystal formation and growth, so that the crystal size, shape, structure and morphology 
could be consequently modified (Kuldipkumar et al., 2007; Kulkarni et al., 2013; Yang et 
al., 2013). Currently it is widely believed that the impurity affects this process by 
incorporating into the crystal lattice or being adsorbed at some certain surfaces of the 
crystal (Kubota et al., 1997); as a result, it may alter the surface free energy of crystals 
and may block sites which are essential for incorporation of solute into the crystal lattice 
(Cashell et al., 2005). In practice, sometimes even small amounts of impurities could 
have significantly on crystallization process.  
In this study, the impurity effect of structure similar additive (L-tyrosine) on the 
crystallization of L-phenylalanine was investigated. Both L-phenylalanine (L-Phe) and L-
tyrosine (L-tyr) are aromatic proteinogenic amino acids and share very similar molecular 
structures as illustrated in Figures 4.1-4.2. L-Tyr and L-Phe can be found in milk, meat, 
fish, and eggs, which increase the possibility of coexistence of these two amino acids. 
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Therefore, study the impurity effect of L-Tyr on the nucleation and growth of L-Phe is of 
practical importance. 
It is widely reported that L-Phe exists in two crystalline forms: anhydrous form and 
monohydrate L-Phe (Cashell et al., 2005; Kee et al., 2009, 2011; Lu et al., 2012; Wang et 
al., 2014). The transition temperature of these two forms is 37℃ in water. Below this 
temperature, the needle-like monohydrate form is more stable; when the crystallization of 
L-Phe in water is performed at temperature higher than 37℃, the rhombic plate-like 
anhydrous form is more stable. Most recently, Williams and his coworker (2013) 
expanded the pseudo-polymorphism of L-Phe by discovering two new crystalline forms 
of L-Phe (hemihydrate phase and a new anhydrate phase), which added the complexity 
and expanded the research possibilities for this system.  
 
 
Figure 4.1 Molecular structure of L-phenylalanine 
 
 
Figure 4.2 Molecular structure of L-tyrosine 
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Several studies have been devoted to the understanding of the impurity effects on the 
crystallization of L-Phe from aqueous solution. Mohan
 
et al.
 
(2001) investigated the 
effects of additives (ammonium sulfate and dextrose) on the pseudo-polymorphs 
transition behavior of L-Phe. Powder X-ray diffraction, micro-images, and solubility 
measurement were applied to identify the presence of polymorphs and analyze the entire 
transformation process. The results demonstrated that ammonium sulfate and dextrose 
could only postpone the transition rate but had no effect on the transition point. The 
decreased transformation rate was due to a reduction of solubility of the anhydrous in the 
presence of impurities, which significantly hindered the mass transfer of L-Phe to the 
crystal surface of monohydrate. Wang and his coauthors (2014) measured the solubility 
of L-phenylalanine anhydrate and monohydrate in pure water and NaCl, KCl, Na2SO4, 
and (NH4)2SO4 aqueous solutions (4.0 g salts/100 g H2O) and determined the 
transformation kinetics between L-Phe anhydrate and monohydrate. Their results indicate 
that the addition of NaCl in the solution significantly increased the transformation rate 
between the two forms. In addition, selective crystallization of L-Phe anhydrate was 
undertaken at temperature below transition point using seeded batch crystallization from 
a mixed solvent system (Kee et al., 2011). The supersaturation profile of the process was 
monitored by in-situ ATR-FTIR and FBRM with concentration feedback control.  
Although effects of a few additives, including electrolytes (NH4)2SO4, NaCl, 
KAl(SO4)2·12H2O, and Al2(SO4)3 and nonelectrolytes dextrose (C6H12O6) and sucrose 
(C12H22O11) on the solubility and polymorphic transformation of L-Phe have been 
reported, none of these additives shows similar molecular structure with L-Phe. Effects of 
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structure similar additives on the crystallization of L-Phe are essential because they can 
selectively inhibit the crystallization of the stable polymorph (monohydrate form) by 
molecular mimicry and help us get the desired anhydrate form of L-Phe. In this study, L-
Tyr was selected as the tailor-made additive during the crystallization of L-Phe. The 
effects of L-Tyr on the solubility, metastable zone width, growth and consequently the 
morphological change of L-Phe were investigated. This study aims to provide an in-depth 
understanding of the impurity-mediated nucleation and crystal growth of L-Phe. 
 
4.2 Material and Methods  
4.2.1 Material  
L-Phenylalanine (>99%) and L-tyrosine (>99%) were purchased from Alfa Aesar (United 
States). Deionized (DI) water was obtained from the Milli-Q Integral 5 system (Millipore, 
Billerica, MA, US). The eluent for the HPLC analysis consisted of a binary mixture of 
methanol with a purity of >99% (Fisher, Canada) and DI water. 
 
4.2.2 Preparation of L-Phe anhydrate and monohydrate 
As reported in many papers, the transition temperature for pseudo-polymorphs of L-Phe 
is 37°C. In order to confirm the anhydrous and hydrate forms of L-Phe, the 
recrystallization of L-Phe were conducted at two different conditions with the starting 
and ending temperature being 65-38°C and 65-35°C, respectively. Consequently, powder 
XRD and DSC were applied to characterize the crystals of L-Phe obtained under the two 
conditions. Recrystallized anhydrate crystals (Figure 4.3) were used in the batch 
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crystallization experiments as seeds with a well-defined rhombic shape as opposed to the 
commercially available crystals, which were irregular platelets. 
 
4.2.3 Solubility and metastable limit measurement  
The solubility of L-Phe in pure DI water, solutions with 2.0wt% and 4.0 wt% L-Tyr was 
measured at various temperatures from 338.15K to 293.15K. For each experiment, excess 
amounts of L-Phe were added to 100mL of solvent in a jacketed glass crystallizer. The 
solution was continuously agitated by a magnetic stirrer at 200rpm for more than 24 
hours. The temperature of solution was controlled using a programmable Julabo FP50 
heating/cooling circulator (Allentown, PA, US). A supersaturated solution would be 
obtained until the solid particles did not dissolve anymore. After that, the solution was 
transferred to a filter to remove the excess solid. 
 
 
Figure 4.3 Micrograms of seed crystals in size range between 212 and 180μm 
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Sample of saturated solution was then taken from the supernatant with syringe equipped 
with a filter (45μm pore size). The filter was heated to the experimental temperature 
before use in order to avoid errors caused by recrystallization or dissolution. The 
saturated solution was diluted 100 times using deionized water and then the concentration 
was analyzed by HPLC.  
The saturated solutions obtained during the solubility measurement were used to measure 
the metastable zone limits and induction time at different temperatures. The temperature 
was decreased at a constant rate of 17°C/h and the stirring speed was fixed at 200 rpm. 
The cooling was processed until the tiny amount of solid crystals was detected, then, the 
induction time was recorded and the metastable zone could be determined. 
 
4.2.4 Seeded batch crystallization of L-Phe in the absence or presence of L-Tyr 
The effect of the trace amount of L-try on the crystal growth of L-Phe was carried out 
using isothermal seeded batch crystallization at 24.0°C. The recrystallized seed crystals 
of L-Phe anhydrate with the size range between 212μm and 180μm were used in the 
batch crystallization process to observe the impact of L-Tye on the growth of anhydrous 
L-Phe.   
The growth of anhydrous L-Phe was performed in pure DI water, solutions with 2.0wt% 
and 4.0 wt% L-Tyr. The supersaturation ratio used in seeded crystallization was S=1.4 
(S=C/Ceq, where C is the actual solution concentration and Ceq is the equilibrium 
concentration). The selected amino acids were added to 10.0 mL DI water in 25.0 mL 
sample vials at 65 °C and brought to supersaturation by cooling to 24 °C. The sample 
vials were placed into a jacketed 1L glass crystallizer for agitation and temperature 
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control by a programmable Julabo FP50 heating/cooling circulator. After keeping the 
temperature at 24℃ for 1 hour, 20 L-Phe anhydrate seeds were added into the clear 
solutions. Crystallization lasted 5 days at 24℃ to observe the growth of the seeded 
crystals. However, due to the relative high supersaturation, secondary nucleation of L-
Phe was observed during the process.   
Final products from seeded batch crystallizations in the presence or absence of L-Tyr 
were collected and the influence of impurity on the growth and polymorphs could be 
investigated by comparing the micrograms, Powder X-ray diffraction patterns, 
Differential scanning calorimetry curves of these crystal products. 
 
4.2.5 Characterization methods 
The morphology of crystals was examined with a scanning electron microscope mlf 650 
FEG (FEI Company, USA) operating at 10kV. The samples were mounted on a stub with 
double-sided adhesive tape and coated with carbon under vacuum prior to observation. 
DSC measurement was carried out on a Mettler Toledo DSC 1 system (Mettler Toledo, 
Canada). Before testing the samples, the calorimeter was calibrated using standard 
indium. Samples (5.0-7.0 mg) were heated from 50 °C to 350 °C at a heating rate of 10 
°C/min in sealed aluminum crucibles under a nitrogen atmosphere. The DSC curves were 
recorded and analyzed using the STAR
e
 software. 
Powder XRD patterns of L-Phe crystals were measured by a Rigaku Ultima-IV X-ray 
diffractometer with a Cu X-ray source and a scintillation detector at room temperature. 
The dried sample crystals were grinded and positioned to the silicon plate at the sample 
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holder. The diffraction angles 2θ ranged from 3 to 50° with a step size of 0.02° two theta 
and a counting time of 1s for each step. Data were processed using the software of MDI-
Jade version 9. 
Agilent 1100 Series HPLC consisting of a quaternary pump, autosampler and a variable 
UV detector, was used to determine the solubility, metastable zone limit and composition 
of the mixed crystals obtained from the growth of anhydrous L-Phe in the presence of L-
Tyr. Chromatographic separations were achieved using a 4.6 × 250 mm C18 column 
(Agilent, USA).The mobile phase was a mixture of methanol and water (30/70, v/v) with 
a flow rate of 0.8mL/min. The whole analyzing process was performed at room 
temperature and the detection wavelength was 260nm. 
 
4.3 Results and Discussion 
4.3.1 Characterization of L-Phe anhydrate and monohydrate 
Figures 4.4-4.6 show the PXRD patterns and DSC curves for the two crystalline forms of 
L-Phe obtained at temperatures above and below the transition point respectively. 
Compared to the reported data
 
(Mohan et al., 2001; Lu et al., 2012), it seems that the 
anhydrous form is more stable when the recrystallization is conducted from 65 to 38 °C. 
On the other hand, the monohydrate one will be more easily formed when the ending 
temperature is 35 °C. For instance, in the powder x-ray diagrams, the anhydrous form has 
characteristic diffraction peaks at 5.75, 17.0, 22.73, 28.52, and 34.43; the monohydrate 
form has peaks at 6.44, 8.5, 10.82 13.8, 15, 17.66, 20.58, 22.28, 22.94, and 26.04. All 
these data are consistent with the results reported by Kee et al. (2009). 
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From the DSC curves, the anhydrous form displays three characteristic peaks at 255.1, 
275.6 and 290.3°C; the monohydrate form shows three endothermic peaks at 249.7, 
277.5, and 290.5°C. The positions of these three kinds of peaks are similar to those 
reported by Lu et al. (2012). Despite of these three obvious peaks, the monohydrate form 
exhibit an endothermic peak at around 82.23 °C in figure 4.6, which stands for the 
dehydration reaction. As a result, the experiments should be operated above 37°C. Hence, 
it was confirmed that the plate-like L-phenylalanine crystals used in the present study 
were indeed the anhydrate. 
 
 
Figure 4.4 Powder X-ray diffraction patterns for two products of L-Phe 
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Figure 4.5 The DSC curves of two products of L-Phe 
 
 
Figure 4.6 The DSC curves of two products of L-Phe from 50 to 150℃ 
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in good agreement with those reported by Mohan et al. (2001) and Zhou et al. (2012). It 
is further confirmed that our experimental method for solubility measurement is quite 
accurate. 
Results from Figure 4.7 demonstrate that solubility of L-Phe in pure water increases with 
the temperature, which indicates that the heat is released when the crystals of L-Phe 
anhydrate forms (Lu et al., 2003). The effect of L-Tyr on the solubility of L-Phe has been 
presented in Figure 4.8. The solubility of L-Phe increases slightly when the L-Tyr is 
present and the increase in solubility is more significant when higher content of L-Tyr is 
used.  
 
 
Figure 4.7 Solubility of L-Phe from 293.15K to 338.15K in pure water (experimental 
result and some data reported in literature) 
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Figure 4.8 The effects of different amounts of L-Tyr on solubility and MSZW of L-Phe 
 
4.3.3 Effect of L-Tyr on primary nucleation of L-Phe 
For the primary nucleation, the rate of nucleation, J, can be expressed in the equation 
below (Mullin et al., 2001): 
 𝐽 = Aexp (
−16𝜋𝛾3𝑣2
3𝐾3𝑇3(𝑙𝑛𝑆)2
)                                                                                                      (4.1) 
This equation shows three main factors: the interfacial tension, γ; the supersaturation, S; 
and the temperature, T. Induction time is an important parameter to monitor the 
nucleation mechanism, which is significantly affected by the supersaturation. Induction 
time is defined as the period of time that elapses between the achievement of 
supersaturation and the appearance of crystals (Mullin et al., 2001).
 
As a result, the value 
of tind will also depend on the detection method for the birth of crystal.  
After making a simplifying assumption, the relationship between the nucleation rate and 
the induction time should be inversely proportional (Mullin et al., 2001).  
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𝑡𝑖𝑛𝑑 ∝ 𝐽
−1                                                                                                                              (4.2) 
Then, the classical nucleation equation (4.1) can therefore be expressed as
 
(Mullin et al., 
2001): 
log 𝑡𝑖𝑛𝑑 ∝ [
𝛾3
𝑇3(log 𝑆)2
]                                                                                                           (4.3) 
Results listed in the Table 4.2 indicate that the induction time decreases with an 
increasing content of L-Tyr, which means the nucleation rate of L-Phe increase due to the 
addition of L-Tyr. This phenomenon should be explained from two aspects. At first, L-
Try brings an obvious effect on the solubility of L-Phe, which may reduce the induction 
time. Second, the L-Try molecule is structurally similar to the L-Phe molecule, which 
shows a possibility, that the L-Tyr molecule will be easily absorbed at the L-Phe crystal 
lattice. The L-Phe has fewer sites to enter and need more energy to form a crystal. These 
two factors work together and lead to a regular impact on the nucleation rate of L-Phe. 
 
Table 4.1 Effect of L-Tyr on the MTZW 
Weight fraction of L-Tyr 
Metastable zone width at different Tini, °C  
20.0 30.0 40.0 50.0 65.0 
0.0% 17.39 17.30 17.19 18.73 18.00 
2.0% 16.58 16.36 16.94 16.28 15.10 
4.0% 14.05 14.01 13.79 13.49 13.50 
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Table 4.2 Effect of L-Tyr on the induction time 
Weight fraction of L-Tyr 
Induction time at different Tini, min  
20.0 °C  30.0 °C 38.0 °C 50.0 °C 65.0 °C 
0.0% 61.40 61.00 60.67 66.10 63.53 
2.0% 58.53 57.73 59.78 57.45 53.30 
4.0% 49.58 49.45 48.67 47.62 47.65 
 
4.3.4 Effect of L-Tyr on the growth and morphology of L-Phe 
Results of isothermal seeded batch crystallization at 24℃ were mainly employed to 
analyze the effect of L-Tyr on the growth and secondary nucleation of L-Phe. This time, 
three different scenarios took place from the three seeded batch crystallization with 
different amount of L-Tyr present in the mother solution (0%, 2.0 wt% and 4.0 wt % L-
Tyr). Crystals obtained from the batch without L-Tyr are the needle-like monohydrate as 
shown in Figures 4.9(a) and 4.10 (a)-(b). However, the plate-like anhydrate form was 
attainable from the batch with 4.0 wt% of L-Tyr (Figures 4.9(b) and 4.10 (c)-(d)), while 
for the batch with 2.0 wt% of L-Tyr, only growth of the seeded L-Phe anhydrate was 
observed without the accompany of the secondary nucleation of L-Phe.   
To confirm the crystal forms obtained from the crystallization with different additive 
contents, further analyses of the harvested crystal by SEM, powder XRD and DSC were 
carried out. Different morphologies of L-Phe crystals can be clearly seen from the SEM 
images illustrated in Figure 4.10. PXRD curves in Figures 4.11-12 demonstrated the 
result that the L-Tyr could inhibit the formation of L-Phe monohydrate and in turn 
accelerate the formation of L-Phe anhydrate. Specifically, in the Figure 4.11, the blue 
curve stood for the crystallization product from the pure L-Phe, which exhibited the 
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characteristic diffraction peaks at 6.6, 9.02, 10.8, 14.92, 17.38, 21.54, 24.44, 26.22, and 
33.08. It agreed with that trend of monohydrate L-Phe. In the Figure 4.12, the red curve 
stood for the crystallization product from the L-Phe with the existence of 4% L-Tyr. This 
curve had characteristic diffraction peaks at 5.52, 16.88, 22.62, 28.38, and 34.26, which 
matched well with the curve of anhydrate form. 
 
 
 
                                           (a)                                                    (b) 
Figure 4.9 Crystal products obtained in the absence (a) and presence (b) of L-Tyr 
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                                     (a)                                                            (b) 
  
                                     (c)                                                           (d) 
Figure 4.10 Scanning electron micrographs of two crystallization products at 24℃: (a), 
(b) L-Phe with 4% L-Tyr; (c), (d) pure L-Phe 
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Figure 4.11 Powder X-ray diffraction patterns of product from pure L-Phe at 24℃ (Jie Lu 
et al., 2012) 
 
 
Figure 4.12 Powder X-ray diffraction patterns of product from L-Phe with 4% L-Tyr at 
24℃ 
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The DSC endothermic peaks of the crystal forms collected from the crystallization with 
the presence (4.0 wt %) of L-Tye and in the absence of L-Tye are compared in Figures 
4.13-15. The melting point of crystals from pure L-Phe was higher than that of crystals 
from L-Phe with 4% L-Tyr. In addition, the curve of pure L-Phe showed an endothermic 
peak at 97.73℃. As a consequence, the crystalline product tended to form the anhydrate 
at the presence of 4% L-Tyr. Actually, this phenomenon was caused by the incorporation 
or adsorption of the L-Tyr molecules into the lattice of L-Phe. This kind of foreign 
molecule occupied the sites which belonged to the L-Phe molecules, so that, the L-Tyr 
finally inhibit the growth in some specific directions and thus modified the shape and size 
of the ultimate products. In the Figure 4.15, the DSC curves of three contrast standard 
samples were drawn and compared with that of final anhydrate product. The result 
showed that the melting point of the anhydrate L-Phe was located between that of the L-
Phe with 1% L-Tyr and L-Phe with 2% L-Tyr. As a result, the purity of final anhydrate 
product is 98%-99%, which seemed qualified enough for the industrial requirement.  
  
Figure 4.13 Differential scanning calorimetry curves of two crystallization forms  
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Figure 4.14 DSC curves of two crystallization forms from 50 to 150℃ 
 
 
Figure 4.15 DSC curves of contrast samples of anhydrate L-Phe to quantify the impurity 
amount in the final product 
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The dramatic morphological changes associated with the growth of L-Phe in the presence 
of L-Tyr reveal the high degree of specificity in the interaction of the foreign molecule 
with the different structured surfaces of the crystalline matrix. Generally, when growth is 
inhibited in a direction perpendicular to a given face, the area of this face is expected to 
increase relative to those of other faces of the same crystal. Differences in the relative 
surface areas of the various faces of pure and affected crystals allow, therefore, 
identification of the affected faces and consequently of the crystallographic directions 
involved. In addition, the presence of tiny amount of L-Tyr (2.0 wt %) can suppress the 
secondary nucleation of L-Phe from aqueous solution although a relative higher 
supersaturation (S=1.4) of L-Phe was used. This may result from changes in the 
equilibrium solubility or the solution structure, or by physical or chemical adsorption of 
the impurity on homogeneous and heterogeneous nuclei (Prasad et al., 2001). Finally, 
different hydrogen bond schemes formed in the presence and absence of L-Tye might 
generate different intermolecular interactions and consequently lead to different 
crystalline packing of L-Phe.  
 
4.4 Conclusion 
The two polymorphs of L-Phe were firstly obtained and identified by applying the 
Powder PXRD and DSC techniques. The results were confirmed by comparing with the 
reported data. After that, the effects of L-Tyr on the solubility, crystal nucleation, growth 
and polymorphs of L-Phe were investigated, respectively. The results showed that the 
existence of L-Tyr could increase the solubility and narrow the MTZW thus promote the 
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nucleation process. This kind of effect became more significant with the increase of the 
impurity concentration.  
The effects of L-Tyr on the crystal growth and polymorphs were studied at room 
temperature (24.0 °C). The transformation behavior of L-Phe could be observed at the 
presence of L-Tyr, which indicated that L-Tyr could suppress the formation of 
monohydrate form. In addition, the purity of solid product from L-Phe solution with 4% 
L-Tyr was found to be around 98%-99%. As the anhydrate L-Phe was favored by the 
industrial demand, this discovery seemed useful and practical to apply to the industrial 
scale. In the further researching work, this specific influence at other temperatures should 
be investigated and the different concentration of impurity should be properly added and 
compared. 
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Chapter 5 Conclusions and Recommendations 
 
5.1 Conclusions 
This thesis mainly focuses on the analysis of aromatic amino acids, which not only have 
the chiral property but also act as the building blocks of protein. L-Phe, L-Tyr, and L-Try 
were chosen as the systems to be investigated from the following two aspects. In the 
chapter 3, the characterization of L-Try was conducted by applying diverse recognition 
methods. All the results reached an agreement and thus the existence of a rare solid 
solution system can be finally confirmed. In the chapter 4, the crystallization with the 
presence of impurity was studied, in which the L-Tyr worked as the impurity and the L-
Phe was the solvent. The influence of the L-Tyr on the crystallization of L-Phe was 
discussed from solubility, crystal nucleation and growth rate, and polymorphism. In one 
word, this research can provide an explicit and effective approach to characterize a chiral 
system before other further analyses and the production steps. In addition, the impurity 
effect is also an important factor which we should seriously consider in the crystallization 
process.  
 
5.1.1 Characterization of L-Try 
The characterization of L-Try had never been reported and it was completed in this work 
by using binary melting point diagram (BMP), ternary phase diagram (TPD), powder X-
ray diffraction patterns (PXRD), and single crystal analysis techniques. The absence of 
eutectic point in those two phase diagrams indicated the existence of solid solution. The 
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PXRD patterns confirmed this conclusion again, because the signal curves of the 
racemate, enantionmers, and the mixtures with different compositions showed the similar 
trends. For the results of single crystal analysis, DL- and L-Try exhibited the identical 
conformation and the hydrogen bond geometries and forces are almost the same, which 
supported the results of other methods.  
 
5.1.2 The effect of L-Tyr on the crystallization of L-Phe 
After comparing the solubility data and the crystallization kinetics of pure L-Phe, L-Phe 
with 2% L-Tyr, and L-Phe with 4% L-Tyr in water, the following conclusion can be 
obtained. The existence of L-Tyr can increase the solubility of L-Phe in water and narrow 
the MTZW thus increase the nucleation rate. This influence will be stronger with the 
increasing of the concentration of L-Tyr. In addition, the effect on the crystal growth and 
polymorphism was analyzed at 24℃. The result showed that L-Tyr could retard the 
growth of L-Phe in a certain direction, which induced the formation of polymorphs. As a 
result, the anhydrate L-Phe, the plate-form, is more stable with the presence of L-Tyr at 
24℃. Since the anhydrate L-Phe is highly demanded, the discovery in this research will 
contribute to the production of this important product in the industry. 
 
5.2 Recommendations  
(1) In the future research work, some on-line monitoring techniques can be applied to 
investigate the impurity influence on the crystal nucleation process, which can help to 
determine the MTZW and the induction time more exactly. 
79 
(2) The effect of L-Tyr on the crystal growth and polymorphism of L-Phe at other 
temperatures should be studied, and various concentrations of L-Tyr should be properly 
added. Several groups of experiments need to be replenished and compared with each 
other. 
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